Page last updated: 2024-12-05

malathion

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Malathion: A wide spectrum aliphatic organophosphate insecticide widely used for both domestic and commercial agricultural purposes. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

malathion : A racemate comprising equimolar amounts of (R) and (S)-malathion. It is a broad spectrum organophosphate proinsecticide used to control a wide range of pests including Coleoptera, Diptera, fruit flies, mosquitos and spider mites. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate : A diester that is diethyl succinate in which position 2 is substituted by a (dimethoxyphosphorothioyl)thio group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID4004
CHEMBL ID1200468
CHEBI ID6651
CHEBI ID141474
SCHEMBL ID27358
MeSH IDM0012917

Synonyms (363)

Synonym
sf 60
s-1,o-dimethyl thiophosphate
cythion
malatol
carbophos
fosfotion
experimental insecticide 4049
zithiol
tm-4049
succinic acid, diethyl ester, s-ester with 0,0-dimethyl phosphorodithioate
o,2-dicarbethoxyethyl) thiothionophosphate
malathion e50
malagran
succinic acid, diethyl ester, s-ester with o,o-dimethyl phosphorodithioate
malphos
MLT ,
fyfanon
s-[1,o-dimethyl phosphorodithioate
four thousand forty-nine
prioderm
ethiolacar
mercaptothion
ortho malathion
o,o-dimethyl dithiophosphate of diethyl mercaptosuccinate
taskil
ac 26691
o,2-dikarbetoxylethylditiofosfat
diethyl mercaptosuccinate,o-dimethyl dithiophosphate, s-ester
malaphos
malakill
nsc6524
malafor
chemathion
malamar 50
nci-c00215
s-(1,o-dimethyl-dithiofosfaat
diethyl mercaptosuccinic acid,o-dimethyl phosphorodithioate
malatox
[(dimethoxyphosphinothioyl)thio]butanedioic acid, diethyl ester
siptox i
malation
carbofos
sadophos
1,2-d.(ethoxycarbonyl)dimethyl phosphorothiolothionate
malaspray
0,2-bis(ethoxycarbonyl)ethyl] dithiophosphate
kop-thionkypfosmalacide
emmatos
malamar
insecticide no. 4049
dithiophosphate de o,2-dicarboethoxyethyle)
o,2-dicarbethoxyethyl) phosphorodithioate
carbethoxy malathion
moscarda
malathione
8059hc
fosfothion
etiol
dicarboethoxyethyl o,o-dimethyl phosphorodithioate
diethyl mercaptosuccinate,o-dimethyl phosphorodithioate
karbofos
sumitox
s-(1,o-dimethyl phosphorodithioate
o,2-dicarbethoxyethyl) dithiophosphate
s-(1,o-dimethyl-dithiophasphat
ent 17,034
emmatos extra
diethyl 2-(dimethoxyphosphinothioylthio)succinate
phosphorodithioic acid,0-dimethyl ester, s-ester with diethyl mercaptosuccinate
compound 4049
s-[1,o-dimethyl dithiophosphate
fog 3
o,2-di(ethoxycarbamyl)ethyl phosphorothioate
1,o-dimethyl phosphordithioates
staeubol-puder
s-(1,o-dimetil-ditiofosfato
wln: 2ov1yvo2 & sps & o1 & o1
diethyl mercaptosuccinate,o-dimethyl thiophosphate
[(dimethoxyphophinothioyl)thio]butanedioic acid, diethyl ester
carbetox
phosphothion
oleophosphothion
sadofos
mercaptosuccinic acid diethyl ester,o-dimethyl phosphorothioate
american cyanamid 4,049
o,o-dimethyldithiophosphate diethylmercaptosuccinate
malathon
nsc-6524
KBIO1_001426
DIVK1C_006482
diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate
SPECTRUM_001795
butanedioic acid, [(dimethoxyphosphinothioyl)thio]-, diethyl ester
succinic acid, mercapto-, diethyl ester, s-ester with o,o-dimethyl phosphorodithioate
BSPBIO_002305
SPECTRUM5_001936
NCGC00091902-01
camathion
latka 4049 [czech]
s-(1,2-dicarbethoxyethyl) o,o-dimethylphosphorodithioate
s-(1,2-bis(ethoxycarbonyl)ethyl) o,o-dimethyl phosphorodithioate
brn 1804525
carbetovur
hilthion
diethyl mercaptosuccinate, o,o-dimethyl dithiophosphate, s-ester
ccris 368
dithiophosphate de o,o-dimethyle et de s-(1,2-dicarboethoxyethyle) [french]
kypfos
butanedioic acid, ((dimethoxyphosphinothioyl)thio)-, diethyl ester
TAK ,
butanedioic acid, ((dimethoxyphosphinothioyl)-thio)-, diethyl ester, (+-)-
s-(1,2-dicarbethoxyethyl) o,o-dimethyldithiophosphate
diethyl (+-)-mercaptosuccinate, s-ester with o,o-dimethyl phosphorodithioate
s-(1,2-bis(etossi-carbonil)-etil)-o,o-dimetil-ditiofosfato [italian]
ovide
s-(1,2-bis(carbethoxy)ethyl) o,o-dimethyl dithiophosphate
hsdb 665
carbafos
lice rid
((dimethoxyphosphinothioyl)thio)butanedioic acid diethyl ester
dorthion
diethyl(dimethoxythiophosphorylthio)succinate
o,o-dwumetylo-s-1,2-bis(karboetoksyetylo)-dwutiofosforan [polish]
extermathion
detmol ma
o,o-dimethyl s-1,2-di(ethoxycarbamyl)ethyl phosphorodithioate
cleensheen
o,o-dimethyl-s-1,2-dikarbetoxylethylditiofosfat [czech]
mercaptotion [spanish]
1,2-di(ethoxycarbonyl)ethyl o,o-dimethyl phosphorodithioate
flair
s-(1,2-di(ethoxycarbonyl)ethyl) dimethylphosphorothiolothionate
phosphorodithioic acid, o,o-dimethyl ester, s-ester with diethyl mercaptosuccinate
o,o-dimethyl-s-(1,2-bis(ethoxycarbonyl)ethyl)dithiophosphate
succinic acid, mercapto-, diethyl ester, s-ester with o,o-dimethylphosphorodithioate
malation [polish]
diethyl mercaptosuccinate, o,o-dimethyl phosphorodithioate
calmathion
ai3-17034
s-1,2-bis(ethoxycarbonyl)ethyl-o,o-dimethyl thiophosphate
o,o-dimethyl-s-1,2-(dicarbaethoxyaethyl)-dithiophosphat [german]
einecs 204-497-7
s-(1,2-bis(aethoxy-carbonyl)-aethyl)-o,o-dimethyl-dithiophosphat [german]
malathiazol
celthion
malmed
malathyl
diethyl ((dimethoxyphosphinothioyl)thio)butanedioate
diethyl mercaptosuccinic acid, s-ester of o,o-dimethyl phosphorodithioate
fosfotion 550
s-(1,2-di(ethoxycarbonyl)ethyl) dimethyl phosphorothiolothionate
cimexan
kill-a-mite
ifo 13140
o,o-dimethyl s-(1,2-bis(ethoxycarbonyl)ethyl) dithiophosphate
el 4049
o,o-dimethyl-s-(1,2-dicarbethoxyethyl) thiothionophosphate
kop-thion
malacide
forthion
malataf
diethyl mercaptosuccinic acid o,o-dimethyl phosphorodithioate
malasol
diethyl mercaptosuccinate, o,o-dimethyl thiophosphate
mercaptosuccinic acid diethyl ester
s-(1,2-bis(ethoxy-carbonyl)-ethyl)-o,o-dimethyl-dithiofosfaat [dutch]
diethyl mercaptosuccinate s-ester with o,o-dimethylphosphorodithioate
121-75-5
C07497
malathion
o,o-dimethyl s-1,2-di(ethoxycarbamyl)ethyl
diethyl (dimethoxyphosphinothioylthio)succinate
o,o-dimethyl s-(1,2-dicarbethoxyethyl) dithiophosphate
o,o-dimethyl s-(1,2-bis(ethoxycarbonyl)ethyl)
DB00772
maldison
o,o-dimethyl s-(1,2-dicarbethoxyethyl)phosphorodithioate
[(dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester
malathion (usp)
ovide (tn)
D00534
NCGC00091902-02
NCGC00091902-03
KBIO3_001805
KBIOGR_001025
KBIO2_002286
KBIO2_004854
KBIO2_007422
KBIOSS_002288
SPBIO_001076
SPECTRUM3_000813
SPECTRUM4_000653
SPECPLUS_000386
SPECTRUM2_001228
NCGC00091902-07
NCGC00091902-05
NCGC00091902-06
ent-17034
chebi:6651
CHEMBL1200468
L001138
inchi=1/c10h19o6ps2/c1-5-15-9(11)7-8(10(12)16-6-2)19-17(18,13-3)14-4/h8h,5-7h2,1-4h3
jxsjbgjigxnwci-uhfffaoysa-
diethyl 2-dimethoxyphosphinothioylsulfanylbutanedioate
CHEBI:141474
NCGC00091902-09
NCGC00091902-08
HMS3264A04
o,o-dwumetylo-s-1,2-bis(karboetoksyetylo)-dwutiofosforan
unii-u5n7su872w
s-(1,2-bis(aethoxy-carbonyl)-aethyl)-o,o-dimethyl-dithiophosphat
s-(1,2-bis(ethoxy-carbonyl)-ethyl)-o,o-dimethyl-dithiofosfaat
u5n7su872w ,
s-(1,2-bis(etossi-carbonil)-etil)-o,o-dimetil-ditiofosfato
latka 4049
mercaptotion
malathion [usp:ban]
o,o-dimethyl-s-1,2-(dicarbaethoxyaethyl)-dithiophosphat
dithiophosphate de o,o-dimethyle et de s-(1,2-dicarboethoxyethyle)
o,o-dimethyl-s-1,2-dikarbetoxylethylditiofosfat
dtxcid80791
dtxsid4020791 ,
tox21_400048
cas-121-75-5
nsc-755848
nsc755848
pharmakon1600-00330021
tox21_111175
bdbm85372
cas_121-75-5
CCG-39152
derbac-m
vegfru malatox
sadofos 30
oms 1
vetiol
maltox mlt
hilthion 25wdp
organoderm
malathiozoo
malaphele
malathion 60
maltox
AKOS015897264
butanedioic acid, ((dimethoxyphosphinothioyl)-thio)-, diethyl ester, (+/-)-
malathion [mi]
diethyl 2-((dimethoxyphosphinothioyl)thio)butanedioate
malathion [ep monograph]
malathion [vandf]
malathion [usp monograph]
malathion [who-dd]
malathion [hsdb]
malathion [mart.]
diethyl (+/-)-mercaptosuccinate, s-ester with o,o-dimethyl phosphorodithioate
malathion [iarc]
malathion [usp-rs]
malathion [orange book]
SCHEMBL27358
NCGC00091902-11
tox21_111175_1
CS-4416
1,2-di(ethoxycarbonyl)ethyl o,o-dimethyl phosphordithioate
malathyne
malathion ulv
gammaxine
s-[1,2-bis(ethoxycarbonyl)ethyl] o,o-dimethyl phosphorodithioate
diethyl mercaptosuccinate s-ester with o,o-dimethyl phosphorodithioate
mercaptosuccinic acid diethyl ester, s-ester with o,o-dimethyl phosphorothioate
o,o-dimethyl s-(1,2-dicarbethoxyethyl) thiothionophosphate
diethyl 2-[(dimethoxyphosphorothioyl)sulfanyl]succinate #
o,o-dimethyl dithiophosphate diethylmercaptosuccinate
suleo m
diethyl (dimethoxyphosphinothioylthio) butanedioate
o,o-dimethyl s-1,2-di(ethoxycarbamyl)ethyl phosphorothioate
o,o-dimethyl-s-(1,2-di(ethoxycarbonyl)ethyl) phosphorodithioate
o,o-dimethyl s-(1,2-dicarbethoxyethyl) phosphorodithioate
radotion
s-[1,2-bis(carbethoxy)ethyl] o,o-dimethyl dithiophosphate
s-(1,2-dicarbethoxyethyl) o,o-dimethyl phosphorodithioate
s-(1,2-bis(aethoxy-carbonyl)-aethyl)-o,o-dimethyl-dithiophasphat
diethyl [(dimethoxyphosphinothoiyl)thio]butanedioate
malathine
HY-B0943
AB00053015_02
1,4-diethyl 2-{[dimethoxy(sulfanylidene)-$l^{5}-phosphanyl]sulfanyl}butanedioate
J-004630
malathion, certified reference material, tracecert(r)
sr-01000942243
SR-01000942243-1
malathion, pestanal(r), analytical standard
malathion, united states pharmacopeia (usp) reference standard
malathion, european pharmacopoeia (ep) reference standard
malathion, analytical standard
malathion, vial of 1 g, analytical standard
malathion 100 microg/ml in cyclohexane
diethyl 2-(dimethoxyphosphorothioylthio)succinate
FT-0701077
Q423005
AS-13786
malathion 1000 microg/ml in toluene
o,o-dimethyl s-[1,2-bis(ethoxy carbonyl)ethyl]dithiophosphate
malathion 1000 microg/ml in acetone
1,4-diethyl 2-{[dimethoxy(sulfanylidene)-lambda5-phosphanyl]sulfanyl}butanedioate
EN300-7479313
diethyl (dimethoxyphosphinothioylthio) succinate
malathyl lv concentrate & ulv concentrate
s-(1,2-dicarbethoxyethyl)-o,o-dimethyldithiophosphate
o,o-dimethyl-s-(1,2-dicarbethoxyethyl) dithiophosphate
s-(1,2-bis(ethoxycarbonyl) ethyl)o,o-dimethyl-phosphorodithioate
detmol malathion
celthign
s-(1,2-bis(ethoxycarbonyl)ethyl) o,o-dimethyl thiophosphate
malathion (ep monograph)
malathion (iarc)
s-(1,2-bis(ethoxycarbonyl)ethyl o,o-dimethylphosphorodithioate
s-1,2-bis(ethoxycarbonyl)ethyl o,o-dimethylphosphorodithioate
s-o,o-dimethyl-phosphorodithioate
detmol ma 96%
malathion ulv concentrate
stcc 4941156
diethyl mercaptosuccinate-o,o-dimethyl dithiophosphate, s-ester
duramitex
insecticide 4049
malathion (usp-rs)
greenfly aerosol spray
diethyl mercaptosuccinate-s-ester with o,o-dimethylphosphorodithioate
tm 4049
fisons greenfly and blackfly killer
phosphorodithioic acid-o,o-dimethyl ester-s-ester with diethyl mercaptosuccinate
butanedioic acid,((dimethoxyphosphinothioyl)thio)-, diethyl ester
malathion lb concentrate
o,o-dimethyl dithiophosphate diethyl mercaptosuccinate
malathion (mart.)
o,o-dimethyl-s-1,2-dikarbetoxyethylditiofosfat
tak (pesticide)
usepa/opp pesticide code: 057701
diethyl 2-((dimethoxyphosphorothioyl)sulfanyl)butanedioate
cromocide
agrichem greenfly spray
detmol 96%
diethyl mercaptosuccinate-o,o-dimethyl phosphorodithioate
eveshield captan/malathion
o,o-dimethyl s-(1,2-bis(ethoxycarbonyl)ethyl)dithiophosphate
banmite
o,o-dimethyl-s-1,2-di(ethoxycarbamyl)ethyl phosphorodithioate
dicarboethoxyethyl-o,o-dimethyl phosphorodithioate
all purpose garden insecticide
diethyl mercaptosuccinate-o,o-dimethyl thiophosphate
1,2-di(ethoxycarbonyl)ethyl-o,o-dimethyl phosphorodithioate
prentox malathion 95% spray
o,o-dimethyl-s-(1,2-dicarbethoxyethyl)phosphorodithioate
mavidan
diethyl (dimethoxyphosphinothiotylthio) butanedioate
malathion (usp monograph)
diethyl mercaptosuccinic acid-o,o-dimethyl phosphorodithioate
s-(1,2-bis(carbethoxy)ethyl)-o,o-dimethyl dithiophosphate
o,o-dimethyl-s-1,2-(dicarbaethoxyaethyl)dithiophosphat
pbi crop saver
s-(1,2-di(ethoxycarbonyl)-ethyl) dimethyl phosphorothiolothionate
cythion insecticide
mercaptosuccinic acid, diethyl ester, s-ester with o,o-dimethyl phosphoro-dithioate
malathion e 50
malathion organophosphorous insecticide

Research Excerpts

Overview

Malathion is a widely used organophosphorus pesticide; it is also a molecule of forensic interest due to its moderate to high toxicity in nontarget organisms, humans included. Malathion functions by acting as an acetylcholinesterase inhibitor.

ExcerptReferenceRelevance
"Malathion is an organophosphate pesticide with high neurotoxicity."( Crocin Protects Malathion-Induced Striatal Biochemical Deficits by Inhibiting Apoptosis and Increasing α-Synuclein in Rats' Striatum.
Ghasemzadeh Rahbardar, M; Hosseinzadeh, H; Mohammadzadeh, L; Razavi, BM, 2022
)
1.79
"Malathion is a widely used organophosphorus pesticide; it is also a molecule of forensic interest due to its moderate to high toxicity in nontarget organisms, humans included. "( Effect of Malathion on the Development of Megaselia scalaris (Loew, 1866) (Diptera: Phoridae), a Forensically Important Fly.
Bravo-Gómez, ME; Castillo-Alanis, LA; Lira-Paredes, AA; Pedraza-Lara, C; Quijano-Mateos, A, 2022
)
2.57
"Malathion is a commercially available insecticide that functions by acting as an acetylcholinesterase inhibitor. "( Towards a comprehensive understanding of malathion degradation: comparison of degradation reactions under alkaline and radical conditions.
Lamb, RW; McAlexander, H; Shukla, MK; Woodley, CM, 2022
)
2.43
"Malathion is an insecticide that is used to control arboviruses and agricultural pests. "( Malathion exposure during juvenile and peripubertal periods downregulate androgen receptor and 17-ß-HSD testicular gene expression and compromised sperm quality in rats.
Erthal, RP; Fernandes, GSA; Frigoli, GF; Siervo, GEML; Verri, WA; Zaninelli, TH, 2023
)
3.8
"Malathion (MAL) is an organophosphate insecticide that inhibits cholinesterases, used to control pests in agriculture and to combat mosquitoes that transmit various arboviruses. "( Long-term and low dose oral malathion exposure causes morphophysiological changes in the colon of rats.
Araújo, EJA; Basso, CR; ErthalL, RP; Fernandes, GSA; Guarnier, FA; Machado, CCA; Pupim, ACE; Simão, ANC; Sodré, GBC; Watanabe, PS, 2023
)
2.65
"Malathion (MAL) is a common organophosphorus pesticide and affects both animal and human reproduction. "( Melatonin protects against defects induced by malathion during porcine oocyte maturation.
Chen, L; Huo, LJ; Liu, X; Miao, YL; Zhang, JJ; Zhang, X; Zhao, S; Zhou, J, 2020
)
2.26
"Malathion (MAL) is an organophosphorus (OP) insecticide. "( Development of a molecularly imprinted polymer electrochemical sensor and its application for sensitive detection and determination of malathion in olive fruits and oils.
Aghoutane, Y; Bouchikhi, B; Diouf, A; El Bari, N; Österlund, L, 2020
)
2.2
"Malathion is a potent organophosphate insecticide that inhibits acetylcholinesterase (AChE) enzyme. "( Protective effects of thymoquinone and diallyl sulphide against malathion-induced toxicity in rats.
Abdel-Daim, MM; Abushouk, AI; Aleya, L; Alkahtani, S; Bin-Jumah, M; Bungău, SG; El-Kott, AF; Shati, AA, 2020
)
2.24
"Malathion is a highly toxic organophosphate insecticide, being one of the most widely used in the world and is generally used for insect control in food production. "( Ecotoxicity of malathion pesticide and its genotoxic effects over the biomarker comet assay in Daphnia magna.
Knapik, LFO; Ramsdorf, W, 2020
)
2.35
"Malathion is a widely used chiral phosphorus insecticide, which has a more toxic chiral metabolite malaoxon. "( Enantiomeric separation of malathion and malaoxon and the chiral residue analysis in food and environmental matrix.
Hua, Y; Liu, D; Wang, P; Zhou, Q; Zhou, Z, 2020
)
2.3
"Malathion is an organophosphate insecticide used in agriculture and for controlling vector-borne diseases such as Zika. "( Exposure to low doses of malathion during juvenile and peripubertal periods impairs testicular and sperm parameters in rats: Role of oxidative stress and testosterone.
Alves Fernandes, GS; Cecchini, R; Cunha, FQ; Erthal, RP; Fattori, V; Guarnier, FA; Luiz, KG; Pescim, RR; Staurengo-Ferrari, L; Verri, WA, 2020
)
2.3
"Malathion is an organophosphate pesticide widely used for agricultural crops and for vector control of "( Impairment of postnatal epididymal development and immune microenvironment following administration of low doses of malathion during juvenile and peripubertal periods of rats.
Erthal, RP; Fattori, V; Fernandes, G; Pescim, RR; Siervo, G; Staurengo-Ferrari, L; Verri, WA, 2020
)
2.21
"Malathion is an organophosphorus pesticide which could remain in agricultural products and exert irreversible harmful effects on human health. "( Ultra-sensitive detection of malathion residues using FRET-based upconversion fluorescence sensor in food.
Ali, S; Chen, Q; Hassan, MM; Ouyang, Q; Sheng, R; Wang, A; Wang, P; Zareef, M, 2020
)
2.29
"Malathion is an organophosphorus insecticide and pesticide commonly used in crops and residential applications. "( A fuzzy cognitive map approach to predict the hazardous effects of malathion to environment (air, water and soil).
Kumar, PS; Poomagal, S; Sujatha, R; Vo, DN, 2021
)
2.3
"Malathion is an organophosphorus pesticide that has been broadly used throughout the world to control weeds and pests."( Biochemical changes and antioxidant capacity of naringin and naringenin against malathion toxicity in Saccharomyces cerevisiae.
Erdem Erişir, F; Gerçek, E; Yılmaz, Ö; Zengin, H, 2021
)
1.57
"Malathion is an OP that already has a relationship between its exposure and behavioural changes, although few data still have its effects in a longer exposure protocol."( Potential role of a newly AChE reactivator in the depressive-like behavior induced by malathion.
Bresolin, L; Fidelis, EM; Gervini, V; Pinto Savall, AS; Pinton, S; Quines, CB, 2021
)
1.57
"Malathion is a commonly used organophosphate pesticide that contaminates freshwaters and has strong negative effects on aquatic biota."( Sub-organism (acetylcholinesterase activity), population (survival) and chemical concentration responses reinforce mechanisms of antagonism associated with malathion toxicity.
Bray, J; Chou, A; Elisei, G; Kaserzon, S; Keely-Smith, A; Kefford, BJ; Miranda, A; Nichols, SJ; Nugegoda, D; Thompson, R, 2021
)
1.54
"Malathion is a high-efficiency organic phosphorus broad-spectrum insecticide which is commonly used in agricultural production, sanitation and epidemic prevention. "( Resveratrol ameliorates malathion-induced estrus cycle disorder through attenuating the ovarian tissue oxidative stress, autophagy and apoptosis.
Jiao, J; Kou, Z; Pang, W; Wang, C; Yong, W, 2021
)
2.37
"Malathion is a commercially available insecticide that functions by acting as an acetylcholinesterase inhibitor. "( Towards a comprehensive understanding of malathion degradation: theoretical investigation of degradation pathways and related kinetics under alkaline conditions.
Lamb, RW; McAlexander, H; Shukla, MK; Woodley, CM, 2021
)
2.33
"Malathion is an organophosphate insecticide and a next-generation pesticide."( Chloroorganic (DDT) and organophosphate (malathion) insecticides impair the motor function of the bovine cervix.
Mlynarczuk, J; Wrobel, MH, 2021
)
1.61
"Malathion is an organophosphate insecticide and can induce the production of reactive oxygen species (ROS) and cause the intracellular oxidative stress."( Overexpression of Mn-superoxide dismutase in Oxya chinensis mediates increased malathion tolerance.
Ma, E; Shi, X; Wu, H; Zhang, J; Zhang, Y, 2017
)
1.4
"Malathion is an organophosphate insecticide that is widely applied and distributed in agricultural and residential settings."( Evaluation on the thyroid disrupting mechanism of malathion in Fischer rat thyroid follicular cell line FRTL-5.
Qiu, Y; Sun, D; Tian, L; Wang, J; Wu, M; Xiong, J; Zhang, H, 2018
)
1.46
"Malathion (MLT) is an organophosphorous type pesticide and having seriously high toxicity and electrochemical platforms for rapid, simple, inexpensive and sensitive determination of pesticides is still a special concern. "( Non-Enzymatic Electrochemical Sensing of Malathion Pesticide in Tomato and Apple Samples Based on Gold Nanoparticles-Chitosan-Ionic Liquid Hybrid Nanocomposite.
Abaci, S; Bolat, G, 2018
)
2.19
"Malathion is an organophosphorus pesticide widely used in agricultural crops, despite its toxicity. "( Growth, photosynthesis and removal responses of the cyanobacteria Chroococcus sp. to malathion and malaoxon.
Alfredo Ortega-Clemente, L; Martínez-Aguilar, K; Pérez-Legaspi, IA; Ramírez-Fuentes, E; Trujillo-Tapia, MN, 2018
)
2.15
"Malathion is a wide spectrum organophosphorothionate insecticide that is frequently found in drinking water, food and foodstuffs. "( Toxic effects and possible mechanisms following malathion exposure in porcine granulosa cells.
Luo, SM; Ma, JY; Shen, W; Wang, W; Yang, LL; Yin, S; Zhao, Y, 2018
)
2.18
"Isomalathion is a major impurity of technical grade malathion, one of the most abundantly applied insecticides; however little is known about its hepatotoxicity. "( Impact of isomalathion on malathion cytotoxicity and genotoxicity in human HepaRG cells.
Guillouzo, A; Josse, R; Savary, CC; Sharanek, A, 2014
)
1.39
"Malathion is a common pesticide used to control insects in agricultural, domestic and industrial sectors in different parts of the world. "( Effect of malathion on the demography of Daphnia pulex Leydig and Diaphanosoma birgei Korinek (Cladocera).
Bravo-Hernández, E; Nandini, S; Sarma, SS, 2014
)
2.25
"Malathion is an organophosphorous insecticide for controlling insects on fruits and vegetables, miscellaneous household insects, and animal parasites. "( Preparation of malathion MIP-SPE and its application in environmental analysis.
Ding, Y; Guo, P; Shi, L; Xing, M; Yang, H; Zhan, CR; Zhu, JX; Zuo, HG, 2015
)
2.21
"Malathion is an organophosphorus pesticide that extensively used in agriculture and veterinary practices. "( Effect of low-dose malathion on the gonadal development of adult rare minnow Gobiocypris rarus.
Guan, Y; Wang, Z; Wu, L; Zhang, G; Zhang, Y, 2016
)
2.21
"Malathion (MLT) is an organophosphate (OP) pesticide widely used in agriculture and for domestic purposes for several years. "( Protective effect of intravenous lipid emulsion treatment on malathion-induced ovarian toxicity in female rats.
Alici, O; Butun, I; Delibas, IB; Karsli, MF; Nursal, AF; Ozsoy, AZ; Tas, U; Uysal, M, 2016
)
2.12
"Malathion is an insecticide widely used in agriculture and in public health programs that when used indiscriminately in large amounts can cause environmental pollution and risk to human health. "( DNA damage after acute and chronic treatment with malathion in rats.
Andrade, VM; Comim, CM; Dagostim, G; Leffa, DD; Nuernberg, H; Padilha, PT; Paula, MM; Quevedo, J; Réus, GZ; Stringari, RB; Tavares, P; Valvassori, SS, 2008
)
2.04
"Malathion is an organophosphate (OP) pesticide that has been shown to induce oxidative stress in erythrocytes through the generation of free radicals and alteration of the cellular antioxidant defense system. "( Malathion-induced oxidative stress in human erythrocytes and the protective effect of vitamins C and E in vitro.
Durak, D; Kalender, S; Kalender, Y; Ogutcu, A; Uzun, FG; Uzunhisarcikli, M, 2009
)
3.24
"Malathion is a widely organphosphorus insecticide used in agriculture, which shows strong insecticidal effects. "( Metabolic disorders of acute exposure to malathion in adult Wistar rats.
Annabi, AB; El Elj, N; El-Fazaa, S; Gharbi, N; Kamoun, A; Lasram, MM; Selmi, S, 2009
)
2.06
"Malathion is an organophosphate pesticide that is known for its high toxicity to insects and low to moderate potency to humans and other mammals. "( Malathion-induced oxidative stress, cytotoxicity, and genotoxicity in human liver carcinoma (HepG2) cells.
Moore, PD; Tchounwou, PB; Yedjou, CG, 2010
)
3.25
"Malathion is an under-recognized and under-utilized therapy for head lice and scabies largely due to misperceptions about its safety profile. "( Malathion for head lice and scabies: treatment and safety considerations.
Idriss, S; Levitt, J, 2009
)
3.24
"Malathion is an organophosphate (OP) pesticide whose toxicity depends on its bioactivation to malaoxon. "( In vitro reactivating effects of standard and newly developed oximes on malaoxon-inhibited mouse brain acetylcholinesterase.
da Rocha, JB; Dafre, AL; de Bem, AF; dos Santos, AA; dos Santos, DB; Farina, M; Kuca, K; Souza, DO, 2010
)
1.8
"Malathion is a well known pesticide and is commonly used in many agricultural and non-agricultural settings. "( Cytogenetic evaluation of malathion-induced toxicity in Sprague-Dawley rats.
Moore, PD; Patlolla, AK; Tchounwou, PB, 2011
)
2.11
"Malathion is an organophosphate insecticide that is used for the control of adult mosquitoes and agricultural pests. "( Strain specific differences in intraspecific competition in Aedes albopictus (Diptera: Culicidae).
Afify, A; Gaugler, R; Kesavaraju, B, 2012
)
1.82
"Malathion is an organophosphorous (OP) insecticide widely used for crop protection. "( Absorption and excretion of organophosphorous insecticide biomarkers of malathion in the rat: implications for overestimation bias and exposure misclassification from environmental biomonitoring.
Chen, L; Ginevan, M; Krieger, R; Pan, C; Ross, J; Vega, H; Zhao, T, 2013
)
2.06
"Malathion (MA) is a widely used insecticide in México. "( Toxic effect and bioavailability of malathion spiked in natural sediments from the Ignacio Ramirez Dam on the snail Stagnicola sp.
Chehue, RA; Galar, MM; Gómez-Oliván, L; López López, E; Martínez-Tabche, L; Olvera, HE; Terron Sierra, O, 2002
)
2.03
"Malathion is a classic example; it is sprayed over aquatic habitats to control mosquitoes that carry malaria and the West Nile virus, yet we know little about its effect on amphibians."( Synergistic impacts of malathion and predatory stress on six species of North American tadpoles.
Relyea, RA, 2004
)
1.36
"Malathion is an organophosphorus insecticide commonly used in crops and indoor applications. "( Evaluation of a novel malathion immunoassay for groundwater and surface water analysis.
Bañuls, MJ; Brun, EM; Gabaldón, JA; Garcés-Garćia, M; Maquieira, A; Puchades, R, 2005
)
2.09
"Malathion is an organophosphorous pesticide widely used to control mosquitoes in urban areas and pests, such as boll weevils, in agricultural areas. "( The pesticide malathion reduces survival and growth in developing zebrafish.
Cook, LW; Lom, B; Paradise, CJ, 2005
)
2.13
"Malathion is a highly soluble organophosphate insecticide that is widely used in agriculture and mosquito eradication campaigns. "( Ecological performance of red drum (Sciaenops ocellatus) larvae exposed to environmental levels of the insecticide malathion.
Del Carmen Alvarez, M; Fuiman, LA, 2006
)
1.99
"Malathion is a pesticide with high potential for human exposure. "( Malathion-induced oxidative stress in rat brain regions.
Dal-Pizzol, F; Feier, G; Fortunato, JJ; Petronilho, FC; Quevedo, J; Vitali, AM, 2006
)
3.22
"Malathion is a pesticide used on a large scale and with high potential risk for human exposure. "( Mitochondrial respiratory dysfunction and oxidative stress after chronic malathion exposure.
Dal-Pizzol, F; Delgado, EH; Quevedo, JL; Streck, EL, 2006
)
2.01
"Malathion is an organophosphate widely used as an insecticide in agriculture and in public health programs, causing risk to human health. "( Zinc attenuates malathion-induced depressant-like behavior and confers neuroprotection in the rat brain.
Assini, F; Brocardo, PS; Dafre, AL; Franco, JL; Müller, YM; Pandolfo, P; Rodrigues, AL; Takahashi, RN, 2007
)
2.13
"Malathion is a widely used pesticide and there is evidence that it could alter mammal's germ and somatic cells, as well as cell lines. "( Gene expression analysis on the early development of pig embryos exposed to malathion.
Betancourt, M; Bonilla, E; Cortés, L; Ducolomb, Y; González-Márquez, H; Hernández-Hernández, F; Salazar, Z,
)
1.8
"Malathion is an organophosphate insecticide that has been widely used for both domestic and commercial agricultural purposes. "( Involvement of chromosomally-encoded genes in malathion utilization by Pseudomonas aeruginosa AA112.
Abo-Amer, AE, 2007
)
2.04
"Malathion is a highly neurotoxic pesticide widely used in daily life. "( Dendritic morphology on neurons from prefrontal cortex, hippocampus, and nucleus accumbens is altered in adult male mice exposed to repeated low dose of malathion.
Campaña, AD; De La Cruz, F; Flores, G; Gamboa, C; Gómez-Villalobos, Mde J; Sanchez, F; Zamudio, S, 2008
)
1.99
"Malathion is a widely used pesticide with high potential for human exposure. "( Increased frequency of specific genomic deletions resulting from in vitro malathion exposure.
Albertini, RJ; Nicklas, JA; O'Neill, JP; Pluth, JM, 1996
)
1.97
"Malathion((R)) is a widely used organophosphorate agropesticide. "( Morphological alterations in mouse testis by a single dose of malathion.
Bustos-Obregón, E; Contreras, HR, 1999
)
1.99
"Malathion is a widely used organophosphate pesticide that modulates immune function at noncholinergic doses. "( Mechanism of the modulation of murine peritoneal cell function and mast cell degranulation by low doses of malathion.
Ellefson, D; Rodgers, K, 1992
)
1.94
"Malathion is an organophosphate pesticide that can cause respiratory failure and death in humans. "( Limited effectiveness of charcoal hemoperfusion in malathion poisoning.
Audette, RJ; Burgess, ED, 1990
)
1.97
"Malathion is an organophosphate insecticide that is toxic to humans. "( The use of inhaled nebulized atropine for the treatment of malathion poisoning.
Shockley, LW, 1989
)
1.96
"Malathion is an agent acting on the neuromuscular system."( Amyoplasia congenita-like condition and maternal malathion exposure.
Hageman, G; Lindhout, D, 1987
)
1.25

Effects

Malathion has a teratogenic effect on mice spermatid differentiation. It compromises mostly the flagella, perhaps due to an alkylating effect.

Malathion 0.5% has been the most prescribed pediculicide in the United Kingdom for around 10 years. Malathion has a teratogenic effect on mice spermatid differentiation, which compromises mostly the flagella.

ExcerptReferenceRelevance
"Malathion has a broad range of toxicities while its reproductive effects have not been fully elucidated. "( Malathion-induced testicular toxicity is associated with spermatogenic apoptosis and alterations in testicular enzymes and hormone levels in male Wistar rats.
Geng, X; Ng, JC; Peng, C; Shao, H; Zhang, Z, 2015
)
3.3
"Malathion has a teratogenic effect on mice spermatid differentiation, which compromises mostly the flagella, perhaps due to an alkylating effect that disturbs the normal assembling of tail structural protein components."( Morphological alterations in mouse testis by a single dose of malathion.
Bustos-Obregón, E; Contreras, HR, 1999
)
1.27
"Malathion has been widely used worldwide in arbovirus control programs. "( Carcinogenicity and mutagenicity of malathion and its two analogues: a systematic review.
Bastos, AFTL; Bastos, PL; Gurgel, ADM; Gurgel, IGD, 2020
)
2.28
"Malathion toxicity has been related to the inhibition of acetylcholinesterase, induction of oxidative stress, liver damage and impairment of kidney function as well as hematotoxicity. "( Effects of N-acetyl-l-cysteine, in vivo, against pathological changes induced by malathion.
Abdelmoula, J; Annabi, A; Bini Douib, I; Bouzid, K; Dhouib, H; El Elj, N; El Fazaa, S; Gharbi, N; Lasram, MM, 2014
)
2.07
"Malathion has a broad range of toxicities while its reproductive effects have not been fully elucidated. "( Malathion-induced testicular toxicity is associated with spermatogenic apoptosis and alterations in testicular enzymes and hormone levels in male Wistar rats.
Geng, X; Ng, JC; Peng, C; Shao, H; Zhang, Z, 2015
)
3.3
"Malathion toxicity has been related to the inhibition of acetylcholinesterase and induction of oxidative stress, while zinc has been shown to possess neuroprotective effects in experimental and clinical studies. "( Zinc reverses malathion-induced impairment in antioxidant defenses.
Bainy, AC; Brocardo, PS; Dafre, AL; Farina, M; Franco, JL; Leal, RB; Marques, MR; Mattos, JJ; Posser, T; Rodrigues, AL; Trevisan, R, 2009
)
2.16
"Malathion desulfuration has been characterized in human liver microsomes (HLMs) with a method based on acetylcholinesterase inhibition that is able to detect nanomolar levels of oxon."( Malathion bioactivation in the human liver: the contribution of different cytochrome p450 isoforms.
Buratti, FM; D'Aniello, A; Meneguz, A; Testai, E; Volpe, MT, 2005
)
2.49
"Malathion 0.5% has been the most prescribed pediculicide in the United Kingdom for around 10 years, and is widely used in Europe and North America. "( Randomised, controlled, assessor blind trial comparing 4% dimeticone lotion with 0.5% malathion liquid for head louse infestation.
Burgess, IF; Lee, PN; Matlock, G, 2007
)
2.01
"Malathion has a teratogenic effect on mice spermatid differentiation, which compromises mostly the flagella, perhaps due to an alkylating effect that disturbs the normal assembling of tail structural protein components."( Morphological alterations in mouse testis by a single dose of malathion.
Bustos-Obregón, E; Contreras, HR, 1999
)
1.27
"Malathion resistance has been shown to be the result of a single point mutation in the LcalphaE7 gene in four independently isolated chromosomes of Lucilia cuprina. "( MCE activities and malathion resistances in field populations of the australian sheep blowfly (Lucilia cuprina).
Boyce, TM; Oakeshott, JG; Russell, RJ; Smyth, KA, 2000
)
2.08

Actions

Malathion was chosen because it is the least toxic of the organophosphate cholinesterase-inhibiting pesticides. Malathion could cause an apparent developmental toxicity to zebrafish embryo. The malathion-induced increase in cyclic GMP was time and dose dependent.

ExcerptReferenceRelevance
"Malathion could cause an apparent developmental toxicity to zebrafish embryo, including bradycardia, hatchability reduction and deformity, and abnormal movement patterns in zebrafish larva."( Bioaccumulation, metabolism and toxicological effects of chiral insecticide malathion and its metabolites in zebrafish (Danio rerio).
Cui, J; Jiang, J; Liu, D; Liu, X; Wang, P; Wei, Y; Xiao, S; Zhou, Z, 2023
)
1.86
"Malathion induced an increase in Trkβ and a decrease in BDNF levels in the prefrontal cortex of rats, which were avoided by Cℓ-HIN."( Antidepressant-like effect of (3Z)-5-Chloro-3-(hydroxyimino)indolin-2-one in rats exposed to malathion: Involvement of BDNF-Trkβ pathway and AChE.
Angonesi, V; Bresolin, L; de Ávila, DS; Fidelis, EM; Gervini, VC; Pinton, S; Puntel, RL; Quines, C; Roos, DH; Savall, ASP, 2020
)
1.5
"Malathion induced an increase in activities of hepatocellular enzymes in plasma, lipid peroxidation index, CD3(+)/CD4(+) and CD3(+)/CD4(+) percent and pro-inflammatory cytokines, when decreased antioxidant status in liver was noted. "( Antioxidant and anti-inflammatory effects of N-acetylcysteine against malathion-induced liver damages and immunotoxicity in rats.
Abdelmoula, J; Ahmed, MB; Annabi, A; Belhadjhmida, N; Bouzid, K; Dhouib, IB; El Fazaa, S; Gharbi, N; Lamine, AJ; Lasram, MM, 2014
)
2.08
"Malathion did not cause any significant changes in the comet length of the lymphocytes, throughout the range of concentrations tested."( In vitro studies on the genotoxicity of the organophosphorus insecticide malathion and its two analogues.
Błasiak, J; Jałoszynski, P; Szyfter, K; Trzeciak, A, 1999
)
1.26
"The malathion-induced increase in cyclic GMP was time and dose dependent."( Correlation between organophosphate poisoning, acetylcholinesterase inhibition, and increased cyclic GMP levels in malathion-treated insects.
Bodnaryk, RP, 1977
)
0.95
"Malathion was chosen because it is the least toxic of the organophosphate cholinesterase-inhibiting pesticides."( Dietary fat alteration of plasma cholinesterase response to malathion.
Davidson, PP, 1975
)
1.22
"Malathion seems to increase the plasma T3 level either by stimulating the extrathyroidal conversion of T4 to T3 or by reducing T3 excretion, thereby increasing plasma T3 and the T3/T4 ratio in this fish."( Effect of pesticide on circulating thyroid hormone levels in the freshwater catfish, Heteropneustes fossilis (Bloch).
Singh, TP; Yadav, AK, 1986
)
0.99
"Malathion might inhibit the effect of BPMC on the monoaminergic nerves, thereby markedly potentiating the lethal effect of BPMC."( Contribution of monoaminergic nervous system in potentiation of 2-sec-butylphenyl N-methylcarbamate (BPMC) toxicity by malathion in male mice.
Shirasu, Y; Takahashi, H; Tanaka, J; Tsuda, S, 1987
)
1.2

Treatment

Malathion treatments (30 and 100 mg/kg, s.c.) did not affect the body weight of animals. Malathion-treated rats showed increased glycemia, insulinemia and glycated hemoglobin level. The malathion plus vitamin-treated group did not differ from the control group in t.

ExcerptReferenceRelevance
"When malathion-treated rats were compared with control, a leukocytosis and reduced hemoglobin (HGB) content were detected."( Effects of N-acetyl-l-cysteine, in vivo, against pathological changes induced by malathion.
Abdelmoula, J; Annabi, A; Bini Douib, I; Bouzid, K; Dhouib, H; El Elj, N; El Fazaa, S; Gharbi, N; Lasram, MM, 2014
)
1.08
"When malathion-treated rats were compared to NAC supplemented rats, leukocytosis, T cell count and IL-1β, IL-6, INF-γ expression were reduced."( Antioxidant and anti-inflammatory effects of N-acetylcysteine against malathion-induced liver damages and immunotoxicity in rats.
Abdelmoula, J; Ahmed, MB; Annabi, A; Belhadjhmida, N; Bouzid, K; Dhouib, IB; El Fazaa, S; Gharbi, N; Lamine, AJ; Lasram, MM, 2014
)
1.09
"Malathion-treated rats showed increased glycemia, insulinemia and glycated hemoglobin level, HOMA-IR and HOMA-β indices, plasma activities of hepatocellular enzymes, lipid peroxidation index, CD3(+)/CD4(+) and CD3(+)/CD4(+) and pro-inflammatory cytokines when decreased antioxidant status in liver was noted."( Association of inflammatory response and oxidative injury in the pathogenesis of liver steatosis and insulin resistance following subchronic exposure to malathion in rats.
Abdelmoula, J; Ahmed, MB; Annabi, A; Belhadjhmida, N; Bouzid, K; Dhouib, IB; Fazaa, SE; Gharbi, N; Lamine, AJ; Lasram, MM, 2014
)
1.32
"Malathion treatments (30 and 100 mg/kg, s.c.) did not affect the body weight of animals and caused no evident signs of cholinergic toxicity throughout the treatment, although the highest dose (100 mg/kg) was associated with inhibition of AChE activity."( Long-term and low-dose malathion exposure causes cognitive impairment in adult mice: evidence of hippocampal mitochondrial dysfunction, astrogliosis and apoptotic events.
Colle, D; de Bem, AF; de Oliveira, J; dos Santos, AA; dos Santos, DB; Farina, M; Hort, MA; Moreira, EL; Naime, AA; Suñol, C, 2016
)
1.47
"The malathion-treated rats also had significantly lower serum total protein and albumin levels, but the malathion plus vitamin-treated group did not differ from the control group in terms of these parameters."( Malathion-induced hepatotoxicity in rats: the effects of vitamins C and E.
Demir, F; Durak, D; Kalender, S; Kalender, Y; Uzun, FG, 2010
)
2.28
"Malathion treatment had relatively minor effects compared with density, which had significant negative effects on development rate, survivorship to adulthood, body size (wing length) and longevity."( Effects of nutrition and density in Culex pipiens.
Alto, BW; Lampman, RL; Muturi, EJ, 2012
)
1.1
"Malathion treatment for thirty days drastically reduced the food intake and body weight of fish."( Malathion exposure induces the endocrine disruption and growth retardation in the catfish, Clarias batrachus (Linn.).
Kumar, P; Lal, B; Sarang, MK, 2013
)
2.55
"Malathion treatments reduced alfalfa weevil densities significantly (p < 0.01) by 77.9 and 87.4% in 1998 and 1999, respectively."( Effects of neem-based and chemical insecticides on some arthropods in alfalfa.
Kulaz, H; Ozgen, I; Yardim, EN, 2001
)
1.03
"Malathion-treated animals showed a significant reduction in body weight in a dose-dependent manner. "( Effect of malathion on the male reproductive organs of earthworms, Eisenia foetida.
Bustos-Obregon, E; Espinoza-Navarro, O, 2005
)
2.17
"Malathion-treated male moths were 60-96% less likely to locate a sex pheromone source than control moths."( Effects of sublethal doses of malathion on responses to sex pheromones by male Asian corn borer moths, Ostrinia furnacalis (Guenée).
Du, J; Huang, Y; Zhou, H, 2005
)
1.34
"Malathion treatment reduced the intensity of larval competition at high densities by killing part of the population, thereby increasing yield."( Effect of malathion on larval competition in house fly (Diptera: Muscidae) populations.
Jdeidi, T; Kence, M, 1997
)
1.42
"Malathion treatment (>100mg/kg) also increased the level of anti-dsDNA antibodies in the serum of MRL-lpr mice at 19 weeks of age."( Effects of oral administration of malathion on the course of disease in MRL-lpr mice.
Rodgers, KE, 1997
)
1.3
"In malathion treated adrenalectomized animals, changes in the activities of cerebral cholinesterase and succinic dehydrogenase were still present; other changes were, however, abolished by adrenalectomy."( Modification of malathion induced neurochemical changes by adrenalectomy in rats.
Husain, K; Matin, MA; Sattar, S,
)
0.99
"Malathion treatment induced malathion carboxylesterase activity in both liver (50%) and brain (22%), significantly depleted liver glutathione (35%) content with stimulation of glutathione-S-transferase (50%) and inhibited the activity of mixed-function oxidases."( Alterations in xenobiotic metabolizing enzymes in brain and liver of rats coexposed to endosulfan and malathion.
Seth, PK; Srikanth, NS, 1990
)
1.22
"Treatment of malathion-intoxicated rats with DAS or TQ significantly minimized these biochemical and oxidative effects with more frequent reversal to normal ranges of serum biomarkers, tissue oxidative markers, and antioxidant enzymes in the TQ group."( Protective effects of thymoquinone and diallyl sulphide against malathion-induced toxicity in rats.
Abdel-Daim, MM; Abushouk, AI; Aleya, L; Alkahtani, S; Bin-Jumah, M; Bungău, SG; El-Kott, AF; Shati, AA, 2020
)
1.15
"Treatment with malathion and avermectin at LD20 and LD30 concentrations produced no obvious changes in the levels of BdABCHs."( Molecular Characterization and Transcriptional Expression Analysis of ABC Transporter H Subfamily Genes in the Oriental Fruit Fly.
He, W; Miao, ZQ; Wang, JJ; Wang, L; Wei, DD; Xu, HQ; Yang, Y, 2021
)
0.96
"Rats treated with malathion along with neostigmine or neostigmine + atropine showed no change in brain MDA but decreased nitric oxide (-34.2%-48%)."( Protection by Neostigmine and Atropine Against Brain and Liver Injury Induced by Acute Malathion Exposure.
Abdel-Salam, OME; Abdulaziz, AM; Esmail, RSE; Khadrawy, YA; Mohammed, NA; Sleem, AA; Youness, ER, 2018
)
1.03
"Treatment with malathion alone increased the levels of MDA and decreased SOD, CAT, and GPx activities in erythrocytes (P < 0.05)."( Malathion-induced oxidative stress in human erythrocytes and the protective effect of vitamins C and E in vitro.
Durak, D; Kalender, S; Kalender, Y; Ogutcu, A; Uzun, FG; Uzunhisarcikli, M, 2009
)
2.14
"Co-treatment of malathion-exposed rats with vitamins E and C had a protective effect on sperm counts, sperm motility and abnormal sperm numbers, but not on plasma FSH, LH and testosterone levels."( Malathion-induced testicular toxicity in male rats and the protective effect of vitamins C and E.
Demir, F; Durak, D; Kalender, S; Kalender, Y; Uzun, FG, 2009
)
2.13
"Treatment with malathion decreased the body weight and the spermatic viability in spermatheca, altering the cell proliferation and modifying the DNA structure of spermatogonia."( Effect of malathion on the male reproductive organs of earthworms, Eisenia foetida.
Bustos-Obregon, E; Espinoza-Navarro, O, 2005
)
1.08
"Treatment with malathion has favorable efficacy and safety profiles and enables the immediate, safe return to school."( Therapy for head lice based on life cycle, resistance, and safety considerations.
Clark, L; Lebwohl, M; Levitt, J, 2007
)
0.68
"Treatment with malathion resulted in an increase in the level of blood glucose and lactate and reduced cerebral glycogen, 2 hr after its administration. "( Cerebral glycogenolysis and glycolysis in malathion-treated hyperglycaemic animals.
Husain, K; Matin, MA, 1987
)
0.89

Toxicity

Mature male Wistar rats (weighing 300-320 g and each group six animals) were given mala. They were then challenged orally with a toxic dose of the organophosphate insecticide malathion (250 mg/kg body weight) and evaluated 60 min later for muscarinic signs.

ExcerptReferenceRelevance
" Haemoglobin concentration of blood and organ weights were not affected under the toxic conditions."( Studies on L-ascorbic acid metabolism in rats under chronic toxicity due to organophosphorus insecticides: effects of supplementation of L-ascorbic acid in high doses.
Bhattacharyya, A; Chakraborty, D; Chatterjee, GC; Chatterjee, K; Chatterjee, S; Majumdar, K; Sen, A, 1978
)
0.26
" Results indicate that technical grade malathion (95%) as an ultra-low volume spray and at effective insecticidal concentrations in particle sizes having a mass median diameter of about 12 mu is relatively nonhazardous compared to the possible toxic fuel oil effects of a 6% malathion/No."( Preliminary assessment of the acute toxicity of malathion in animals.
Angerhofer, RA; Davenport, CD; Lawson, MA; Pennington, NE; Weeks, MH, 1977
)
0.78
" Extensive research has been done on this process, and irradiation to a maximum dose of 10 kGy is recognized as safe by national and international regulatory agencies."( The effect of gamma-irradiation on the toxicity of malathion in V79 Chinese hamster cells and Molt-4 human lymphocytes.
Delaney, S; Goodwin, M; Szekely, JG, 1992
)
0.54
" Toxic effects were also observed with the polyamines themselves when applied at concentrations similar to the intracellular levels described for rapid-growing organisms."( Effect of exogenously applied polyamines on malathion toxicity in the toad Bufo arenarum Hensel.
Bergoc, RM; Gauna, LE; Pechen de D'Angelo, AM; Venturino, A, 1992
)
0.54
" The only compound toxic to young mosquitofish at maximum field application rates was resmethrin."( Acute toxicity of mosquitocidal compounds to young mosquitofish, Gambusia affinis.
Hallmon, CF; Hester, PG; Olson, MA; Shaffer, KR; Tietze, NS, 1991
)
0.28
"The level of bound malathion residues in treated wheat grain and its toxic effects on rats were investigated."( Toxic effects of bound malathion residues in rats.
Karan, VZ; Nesković, NK; Vitorović, SL; Vojinović, VD, 1991
)
0.92
" The 96-hr safe concentration (SC) was 1 ppm for cythion and 2 ppm for BHC."( Evaluation of toxicity limit and sex hormone production in response to cythion and BHC in the vitellogenic catfish Clarias batrachus.
Singh, S; Singh, TP, 1987
)
0.27
" Pre-treatment of the larvae with acetylcholine via feed, reduces malathion toxicity and conversely, feeding of acetylcholine to malathion-treated larvae reverses the toxic effects."( Therapeutic action of acetylcholine in malathion toxicity.
Pant, R; Ramana, D, 1989
)
0.78
"Malathion-induced marked potentiation of BPMC toxicity (about fivefold) was analyzed by measuring LD50 as an index of acute toxicity."( Contribution of monoaminergic nervous system in potentiation of 2-sec-butylphenyl N-methylcarbamate (BPMC) toxicity by malathion in male mice.
Shirasu, Y; Takahashi, H; Tanaka, J; Tsuda, S, 1987
)
1.92
"88 times more toxic than their technical materials, respectively."( Relative toxicity of technical material and commercial formulation of malathion and endosulfan to a freshwater fish, Channa punctatus (Bloch).
Haider, S; Inbaraj, RM, 1986
)
0.5
" They were then challenged orally with a toxic dose of the organophosphate insecticide malathion (250 mg/kg body weight) and evaluated 60 min later for muscarinic signs (diarrhea, lacrimation, respiratory secretions), nicotinic signs (muscle weakness), plasma cholinesterase activity, and brain acetylcholinesterase activity."( Effects of social stress on the toxicity of malathion in young chickens.
Brown, C; Ehrich, M; Gross, WB,
)
0.62
" This is particularly important in areas where the more toxic compound, fenitrothion, is to be used."( Safety measures associated with the use of organophosphate insecticides in the Haitian malaria control programme.
Hippolyte, R; Hobbs, JH; Miller, S; Ruebush, TK; Warren, M, 1985
)
0.27
") by determining their LC50 and the acute toxic ranges for 24, 48 and 72, and 96-h exposure to Channa punctatus (Bl."( Evaluation of acute toxicity of carbaryl and malathion to freshwater teleosts, Channa punctatus (Bloch) and Heteropneustes fossilis (Bloch).
Gupta, S; Saxena, PK; Singh, VP, 1984
)
0.53
" Toxic effects of human exposure may be influenced by their nutritional status."( Augmented hepatic susceptibility to malathion toxicity in rats on low-protein diets.
Bulusu, S; Chakravarty, I, 1984
)
0.54
"Pretreatment of rats with chloramphenicol (CAP) (100 mg/kg, ip) 30 min prior to a single oral LD50 dose of malathion (MTH) at 340 mg/kg completely protected against MTH-induced signs of cholinergic toxicity."( Effect of chloramphenicol pretreatment on malathion-induced acute toxicity in the rat.
Gupta, RC; Paul, BS; Thornburg, JE; Welsch, F,
)
0.61
" The dimethylphosphorothioates are not toxic to rats (up to 1 g/kg, orally), they do not potentiate malathion toxicity in rats, and do not inhibit carboxylesterase activity in vitro (up to 1 mM concentrations)."( Dimethylphosphorothioates. Reaction with malathion and effect on malathion toxicity.
Aldridge, WN; Bailey, E; Reiner, E; Verschoyle, RD, 1982
)
0.75
"The aerial application of malathion, a widely used organophosphate insecticide, has raised public concerns about potential adverse health effects."( Genotoxicity of malathion in human lymphocytes assessed using the micronucleus assay in vitro and in vivo: a study of malathion-exposed workers.
Kolachana, P; Osorio, AM; Parvatham, S; Reinisch, F; Smith, MT; Titenko-Holland, N; Windham, G, 1997
)
0.94
"3 mg malathion/L were challenged ip with an LD50 dose of the bacterial fish pathogen Yersinia ruckeri."( Mammalian immunoassays for predicting the toxicity of malathion in a laboratory fish model.
Beaman, JR; Finch, R; Gardner, H; Hoffmann, F; Rosencrance, A; Zelikoff, JT, 1999
)
1.07
" The toxic effect of MA on the snail Stagnicola sp was evaluated by biochemical tests of acetylcholinesterase (AchE) activity, protein concentration, lipid peroxidation level (LPL), and lipid content; a toxicokinetic study was also carried out."( Toxic effect and bioavailability of malathion spiked in natural sediments from the Ignacio Ramirez Dam on the snail Stagnicola sp.
Chehue, RA; Galar, MM; Gómez-Oliván, L; López López, E; Martínez-Tabche, L; Olvera, HE; Terron Sierra, O, 2002
)
0.59
"Of the insecticides tested, parathion was found to be the most toxic to larvae."( Toxicity of some newer insecticides to larvae and pupae of Culex fatigans Weidemann.
THEVASAGAYAM, ES, 1957
)
0.24
"Because some strains of body lice are resistant to DDT and gamma-BHC, there is need for other effective, safe chemicals to control them."( Safety of malathion dusting powder for louse control.
HAYES, WJ; MATTSON, AM; SHORT, JG; WITTER, RF, 1960
)
0.64
" In addition, the Food and Drug Administration recently warned of potentially serious adverse effects associated with lindane and recommended strict controls for its use."( Relationship of treatment-resistant head lice to the safety and efficacy of pediculicides.
Burkhart, CG, 2004
)
0.32
" The 96-h LC50 values were determined, as well as safe levels."( Acute toxicity bioassays of mercuric chloride and malathion on air-breathing fish Channa punctatus (Bloch).
Kumar, R; Nagpure, NS; Pandey, S; Sharma, S; Srivastava, SK; Verma, MS, 2005
)
0.58
" The sensitivity and the ability of these endpoints to inform about mode of action (MoA) were established in testing three model toxicants with well-known toxic effects (propranolol, malathion, cadmium)."( Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals.
Fraysse, B; Garric, J; Mons, R, 2006
)
0.53
" The enhanced inhibition of AChE observed with the TLS bioassay during the initial 30 min of photodegradation in case of all four OPs, confirmed the formation of toxic intermediates."( Photodegradation of organophosphorus insecticides - investigations of products and their toxicity using gas chromatography-mass spectrometry and AChE-thermal lens spectrometric bioassay.
Bavcon Kralj, M; Franko, M; Trebse, P, 2007
)
0.34
"Organophosphorus pesticides (OPs) are ubiquitous in the environment and are highly toxic to amphibians."( Comparative toxicity of chlorpyrifos, diazinon, malathion and their oxon derivatives to larval Rana boylii.
Fellers, G; Sparling, DW, 2007
)
0.6
" Treatment with malathion has favorable efficacy and safety profiles and enables the immediate, safe return to school."( Therapy for head lice based on life cycle, resistance, and safety considerations.
Clark, L; Lebwohl, M; Levitt, J, 2007
)
0.69
"Although enantioselectivity in the toxicity of chiral pesticides has received considerable attention over recent years, how coexisting enantiomers interact with each other during their toxic action remains unknown."( Single and joint acute toxicity of isocarbophos enantiomers to Daphnia magna.
Gan, J; Li, L; Lin, K; Liu, W, 2008
)
0.35
" Its toxicity has been associated with the inhibition of acetylcholinesterase activity, leading to the interference with the transmission of nerve impulse, accumulation of acetylcholine at synaptic junctions, and subsequent induction of adverse health effects including headache, dizziness, nausea, vomiting, bradycardia, and miosis."( Malathion-induced oxidative stress, cytotoxicity, and genotoxicity in human liver carcinoma (HepG2) cells.
Moore, PD; Tchounwou, PB; Yedjou, CG, 2010
)
1.8
" However, direct adverse effects of pesticides on embryos and free-living stages of trematodes have not been thoroughly explored, despite the potential for these effects to reduce amphibian trematode infections."( Lack of pesticide toxicity to Echinostoma trivolvis eggs and miracidia.
Raffel, TR; Rohr, JR; Sheingold, JL, 2009
)
0.35
"Mature male Wistar rats (weighing 300-320 g and each group six animals) were given malathion (27 mg/kg; 1/50 of the LD50 for an oral dose), vitamin C (200 mg/kg)+vitamin E (200 mg/kg), or both daily via gavage for 4 weeks."( Malathion-induced hepatotoxicity in rats: the effects of vitamins C and E.
Demir, F; Durak, D; Kalender, S; Kalender, Y; Uzun, FG, 2010
)
2.03
" Elevated numbers of lymphocytes and eosinophils as found in the present study revealed lymphocytosis as well as eosinophilia, suggesting that this was a result of direct stimulation of the immunological defense due to the presence of a toxic substance or may be associated with tissue damage."( Malathion-induced sublethal toxicity on the hematology of cricket frog (Fejervarya limnocharis).
Kundu, CR; Roychoudhury, S, 2009
)
1.8
" The results of cell viability assay and cytoflow assay indicated an obvious enantioselective hepatocyte toxicity of ICP: (-)-ICP was about two times more toxic than (+)-ICP in Hep G2 cells."( Enantioselective cytotoxicity of isocarbophos is mediated by oxidative stress-induced JNK activation in human hepatocytes.
Li, L; Liu, H; Liu, J; Liu, W; Xu, L; Zhou, S, 2010
)
0.36
"2 LD50 = 896 mg/kg) were administered intravenously (iv) 30 minutes after a single intraperitoneal (ip) injection of MAL (0."( Benefit of nanocarrier of magnetic magnesium in rat malathion-induced toxicity and cardiac failure using non-invasive monitoring of electrocardiogram and blood pressure.
Abdollahi, M; Baeeri, M; Karimi, G; Mohammadi, H; Nikfar, S; Sabzevari, O; Shafiee, H, 2011
)
0.62
"Pesticides are toxic chemicals used for agricultural as well as non-agricultural purposes."( Comparative toxicity of the pesticides carbofuran and malathion to the freshwater flagellate Euglena gracilis.
Azizullah, A; Häder, DP; Richter, P, 2011
)
0.62
"Malathion shampoo is safe and effective in the treatment of head lice."( Clinical response and safety of malathion shampoo for treatment of head lice in a primary school.
Chatproedprai, S; Tempark, T; Wananukul, S; Wananukul, W, 2011
)
2.1
" The toxic effect became evident as the cytoplasm of the cells disintegrated and the cells became empty and vacuolated."( Malathion-induced sublethal toxicity on the intestine of cricket frog (Fejervarya limnocharis).
Capcarova, M; Kundu, CR; Roychoudhury, S, 2011
)
1.81
" The sperm counts and sperm motility decreased significantly as the toxic concentration arised."( [Synergistic effect of dichlorvos, dimethoate and malathion mixture on reproduction toxicity in male mice].
Hu, SK; Yan, H; Yang, AM; Yu, Y; Zhang, JH, 2011
)
0.62
" The results suggest the ability of using these plant extracts for wheat grains protection as a safe alternative to insecticides."( Efficacy of some botanical extracts against Trogoderma granarium in wheat grains with toxicity evaluation.
Derbalah, AS, 2012
)
0.38
" Adverse events were limited to itching or stinging."( Safety and efficacy of a non-pesticide-based head lice treatment: results of a randomised comparative trial in children.
Barnes, TM; Greive, KA; Lui, AH; Oppenheim, VM, 2012
)
0.38
"The non-pesticide-based shampoo is significantly more effective in eliminating head lice than malathion foam in children, while being associated with a low incidence of mild, transient adverse events."( Safety and efficacy of a non-pesticide-based head lice treatment: results of a randomised comparative trial in children.
Barnes, TM; Greive, KA; Lui, AH; Oppenheim, VM, 2012
)
0.6
" But, there have not yet any study about effects of sulforophane (SFN) and curcumin (CUR) on the oxidative stress created by acute toxic effects of malathion (MAL) as an OPI often causing human and animal poisoning."( Effects of sulforophane and curcumin on oxidative stress created by acute malathion toxicity in rats.
Alp, A; Alp, H; Aytekin, I; Hatipoglu, NK; Ogun, M, 2012
)
0.81
" This indicated that the R-enantiomer was more toxic than S-enantiomer."( Enantioselective behavior of malathion enantiomers in toxicity to beneficial organisms and their dissipation in vegetables and crops.
Dang, Z; Li, R; Liu, D; Sun, M; Wang, P; Zhou, Z, 2012
)
0.67
" Cytotoxicity in vitro test provided LD50 value of 616 mg/kg suggesting higher toxic potential than is generally published based on in vivo tests on laboratory rodents."( Toxicity hazard of organophosphate insecticide malathion identified by in vitro methods.
Janousek, S; Jira, D; Kejlova, K; Pikula, J; Vitula, F, 2012
)
0.64
"Using in vitro alternative toxicological methods, a higher toxic potential of malathion was demonstrated than is generally declared."( Toxicity hazard of organophosphate insecticide malathion identified by in vitro methods.
Janousek, S; Jira, D; Kejlova, K; Pikula, J; Vitula, F, 2012
)
0.86
" In the first part we showed that malathion exert its toxic effect on growth (biomass) via."( Exogenous osmolytes suppresses the toxic effects of malathion on Anabaena variabilis.
Bano, F; Fatma, T; Habib, K; Ningthoujam, M; Zutshi, S, 2013
)
0.92
" However, the administration of lycopene prevented malathion-induced toxic effects."( Toxic effects of malathion in carp, Cyprinus carpio carpio: protective role of lycopene.
Yonar, SM, 2013
)
0.98
"The study has had some certain evidence that IFE is a promising safe therapy for acutely intoxicated cases by organophosphate."( Is intralipid fat emulsion a promising therapeutic strategy on neurotoxicity induced by malathion in rats?
Alp, H; Basarslan, SK; Evliyaoglu, O; Ozkan, U; Senol, S, 2014
)
0.62
" Twenty micrograms per milliliter LD50 dose of malathion was found to cause stress-mediated responses in H9C2 cell line."( Protective effect of Syzygium cumini against pesticide-induced cardiotoxicity.
Atale, N; Gupta, K; Rani, V, 2014
)
0.66
" Four of 43 postapplication sediment samples were significantly more toxic than their corresponding pre-application samples, but none of the observed toxicity was attributed to the application events."( Monitoring the aquatic toxicity of mosquito vector control spray pesticides to freshwater receiving waters.
Anderson, BS; Denton, D; Isorena, P; Larsen, K; Phillips, BM; Siegler, K; TenBrook, P; Tjeerdema, RS; Voorhees, JP, 2014
)
0.4
" These pesticides are highly toxic to humans and their residues in food pose potential threat to human health."( Combined subchronic toxicity of dichlorvos with malathion or pirimicarb in mice liver and serum: a metabonomic study.
Li, L; Li, W; Liang, YJ; Sun, YJ; Wang, HP; Wang, P; Wu, YJ; Xu, MY; Yang, L, 2014
)
0.66
" The use of zebrafish as a model to study the effects of pesticides on development is an innovative approach yielding relevant implications for determining the potential toxic effects of these pesticides on humans."( Assessment of cardiotoxicity and effects of malathion on the early development of zebrafish (Danio rerio) using computer vision for heart rate quantification.
Simoneschi, D; Simoneschi, F; Todd, NE, 2014
)
0.66
" The toxicological interaction of five organophosphorus pesticides was evaluated using the concentration addition model, the combination index-isobologram equation and the toxic unit approach."( Binary combinations of organophosphorus pesticides exhibit differential toxicity under oxidised and un-oxidised conditions.
Arora, S; Kumar, A, 2015
)
0.42
" For desired toxic effect of an insecticide, apart from other behavioural aspects, toxicity and chemical nature of the molecule are important that may cause irritability in the mosquito to the insecticide affecting the uptake."( Chlorfenapyr: irritant effect compared to other insecticides and its intrinsic toxicity in multiple-insecticide-susceptible and -resistant Anopheles stephensi (Diptera: Culicidae).
Agrawal, OP; Elamathi, N; Raghavendra, K; Sreehari, U; Velamuri, PS; Verma, V, 2015
)
0.42
" In conclusion, malathion was toxic to the liver and kidney and must be avoided and protected by the addition of ginger and zinc mixture."( Protective effect of ginger and zinc chloride mixture on the liver and kidney alterations induced by malathion toxicity.
Attia, HF; Baiomy, AA; Makrum, O; Soliman, MM, 2015
)
0.98
" Hereby, we analyzed the toxic effects of malathion on the histological structure of liver and biochemical parameters in male rats."( Malathion-induced hepatotoxicity in male Wistar rats: biochemical and histopathological studies.
Belaïd-Nouira, Y; Ben Cheikh, H; Boughattas, S; Chargui, I; El Mabrouk, A; Flehi-Slim, I; Haouas, Z; Najjar, MF; Neffati, F, 2015
)
2.12
"The organophosphate pesticide (OP) malathion is highly toxic to freshwater invertebrates, including the cladoceran Daphnia magna, a widely used test organism in ecotoxicology."( Deciphering mechanisms of malathion toxicity under pulse exposure of the freshwater cladoceran Daphnia magna.
Andersen, O; Palmqvist, A; Trac, LN, 2016
)
1.01
" In the past, much of the studies have focused on the toxic effect of contaminants on larvae (tadpoles), juvenile and adult frogs."( Atrazine and malathion shorten the maturation process of Xenopus laevis oocytes and have an adverse effect on early embryo development.
Chen, A; Hetrick, L; Ji, Q; Jing, G; Jocoy, D; Lee, J; Lin, YH; Liu, J; Tsai, LJ, 2016
)
0.8
"Toxicity testing is essential for the protection of human health from exposure to toxic environmental chemicals."( Untargeted metabolomics of neuronal cell culture: A model system for the toxicity testing of insecticide chemical exposure.
Hayton, S; Maker, GL; Mullaney, I; Trengove, RD, 2017
)
0.46
" Evaluating the toxic effects of insecticides on such predatory mites is essential for the success and development of IPM."( Toxicity of six insecticides to predatory mite Amblyseius cucumeris (Oudemans) (Acari: Phytoseiidae) in- and off-field.
Cheng, S; Huang, J; Jiang, H; Lin, R; Ren, X; Wang, S; Yu, C; Yuan, S; Zhang, N; Zhou, X, 2018
)
0.48
" In natural-freshwater assays, at environmentally relevant concentrations, all three pesticides inhibited the preparasitic-stage endpoints; with carbendazim being the most toxic pesticide and the subsequent infectivity of larvae exposed in ovo the most sensitive endpoint."( Susceptibility of Chordodes nobilii (Gordiida, Nematomorpha) to three pesticides: Influence of the water used for dilution on endpoints in an ecotoxicity bioassay.
Achiorno, CL; de Villalobos, C; Ferrari, L, 2018
)
0.48
" In the present study, we found that malathion has obvious toxic effects on cultured porcine granulosa cells in a dose-dependent manner."( Toxic effects and possible mechanisms following malathion exposure in porcine granulosa cells.
Luo, SM; Ma, JY; Shen, W; Wang, W; Yang, LL; Yin, S; Zhao, Y, 2018
)
1.01
" Direct and network meta-analyses were applied to 13 antiscabietic agents on 3 outcomes (cure, persistent itching, and adverse events)."( Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials.
Anothaisintawee, T; Attia, J; Rattanasiri, S; Thadanipon, K; Thakkinstian, A, 2019
)
0.51
" Combination permethrin plus oral ivermectin was ranked highest in terms of cure, topical ivermectin in terms of persistent itching, and synergized pyrethrins in terms of adverse events."( Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials.
Anothaisintawee, T; Attia, J; Rattanasiri, S; Thadanipon, K; Thakkinstian, A, 2019
)
0.51
"Commercial malathion is a racemic mixture that contains two enantiomers, and malathion has adverse effects on mammals."( Different Toxic Effects of Racemate, Enantiomers, and Metabolite of Malathion on HepG2 Cells Using High-Performance Liquid Chromatography-Quadrupole-Time-of-Flight-Based Metabolomics.
Tang, S; Teng, M; Wang, D; Xiang, B; Yan, J; Yan, S; Zhou, Z; Zhu, W, 2019
)
1.14
" Next, three days post fertilization (dpf) zebrafish eleuthero embryos were exposed to the metabolic mix diluted in Danieau's medium for 48 h at 28 °C, followed by a stereomicroscopic examination of the adverse effects induced, if any."( Safety Assessment of Compounds after In Vitro Metabolic Conversion Using Zebrafish Eleuthero Embryos.
Annaert, P; Cabooter, D; De Croze, N; de Witte, P; Giusti, A; Kislyuk, S; Léonard, M; Mignot, M; Nguyen, XB; Nicolaï, J; Ny, A; Oorts, M; Ranieri, C; Wu, X, 2019
)
0.51
" Based on the toxic unit analysis, the toxic interaction of ICP enantiomers for target pests was synergistic effect, while for non-target fish was concentration addition or antagonistic effect."( A systemic study of enantioselectivity of isocarbophos in rice cultivation: Enantioselective bioactivity, toxicity, and environmental fate.
Cang, T; Di, S; Qi, P; Wang, Q; Wang, X; Wang, Z; Xu, H; Xu, M, 2019
)
0.51
" Based on the toxic unit analysis, the additive effect and synergistic effect of ICP enantiomers were found in the four nontarget organisms, and R-(-)-ICP might cooperate the side-effects of S-(+)-ICP."( Comprehensive Study of Isocarbophos to Various Terrestrial Organisms: Enantioselective Bioactivity, Acute Toxicity, and Environmental Behaviors.
Cang, T; Di, S; Qi, P; Wang, Q; Wang, X; Wang, Z; Xu, H; Xu, M, 2019
)
0.51
" Evaluating the toxic effects of individual pesticide may not be enough for protecting ecological environment due to interactions among substances."( Lethal toxicity and gene expression changes in embryonic zebrafish upon exposure to individual and mixture of malathion, chlorpyrifos and lambda-cyhalothrin.
Li, X; Lou, B; Shen, W; Wang, Q; Wang, X; Wang, Y; Xu, C; Yang, G; Yu, R, 2020
)
0.77
"Malathion is a highly toxic organophosphate insecticide, being one of the most widely used in the world and is generally used for insect control in food production."( Ecotoxicity of malathion pesticide and its genotoxic effects over the biomarker comet assay in Daphnia magna.
Knapik, LFO; Ramsdorf, W, 2020
)
2.35
" Malathion toxic effects on liver, kidney, testis, ovaries, lung, pancreas, and blood were also reported."( Organophosphate toxicity: updates of malathion potential toxic effects in mammals and potential treatments.
Badr, AM, 2020
)
1.74
" macrophytes and variable pH) can reduce the aqueous concentrations of malathion, reducing its toxic effects."( Sub-organism (acetylcholinesterase activity), population (survival) and chemical concentration responses reinforce mechanisms of antagonism associated with malathion toxicity.
Bray, J; Chou, A; Elisei, G; Kaserzon, S; Keely-Smith, A; Kefford, BJ; Miranda, A; Nichols, SJ; Nugegoda, D; Thompson, R, 2021
)
1.05
" Conclusion: we found that RFX has a positive regulatory effect on mitophagy and mitochondria biogenesis, which could explain the novel role played by RFX in preventing the adverse effects of malathion on testicular tissue."( Rifaximin Protects against Malathion-Induced Rat Testicular Toxicity: A Possible Clue on Modulating Gut Microbiome and Inhibition of Oxidative Stress by Mitophagy.
Badr, AM; Mosbah, RA; Omar, NN; Rashed, MM; Sarawi, WS, 2022
)
1.21
"The indiscriminate and rampant use of pesticides has raised serious concerns regarding their toxic impact on non-target organisms which underlines need for the development of an effective antidote."( Vitamin B12 alleviates malathion-induced toxicity in zebra fish by regulating cytochrome P450 and PgP expressions.
Bhattacharjee, S; Bhattacharya, S; Karmakar, S; Mandal, DP; Rahaman, A; Sarkar, A; Sen Gupta, P, 2023
)
1.22
" As a result, it was observed that MLT had a toxic effect on the liver and kidney tissues of rats, and it was determined that this toxicity could be alleviated by RUT treatment."( Molecular and biochemical investigation of the protective effects of rutin against liver and kidney toxicity caused by malathion administration in a rat model.
Gur, C; Kandemir, FM, 2023
)
1.12
" Considering the toxic effects on the male genital system of rodents and the possible male reproductive toxicity in humans, it is recommended the decreased use of these pesticides and their replacement for others that show no or few toxic effects for non-target animals."( Malathion or diazinon exposure and male reproductive toxicity: a systematic review of studies performed with rodents.
Delorenzi Schons, D; Leite, GAA, 2023
)
2.35

Pharmacokinetics

ExcerptReferenceRelevance
" A 4-compartment pharmacokinetic model was utilized to model their absorption profile."( Percutaneous absorption, dermatopharmacokinetics and related bio-transformation studies of carbaryl, lindane, malathion, and parathion in isolated perfused porcine skin.
Chang, SK; Dauterman, WC; Riviere, JE; Williams, PL, 1994
)
0.5

Bioavailability

This study investigated the effect of soil organic matter content on the bioavailability of malathion to the common nightcrawler, Lumbricus terrestris. In the birds not exposed to arsenic and/or malathions, the elimination half-life (t(1/2beta), area under the plasma concentration-time curve (AUC), maximum plasma drug concentration (C(max) were 8.

ExcerptReferenceRelevance
" Bioavailability and the effects of lentil-bound residues of malathion in rats were studied."( Bioavailability and toxicological potential of lentil-bound residues of malathion in rats.
Akay, MT; Elcüman, A; Kolankaya, D; Nurcan, M; Yilmazoglu, G, 1992
)
0.76
"76 MBq/mg) to determine the bioavailability of bound residues in rats."( Toxic effects of bound malathion residues in rats.
Karan, VZ; Nesković, NK; Vitorović, SL; Vojinović, VD, 1991
)
0.59
"5-mM spermidine modified malathion uptake and bioavailability increasing the concentration of the xenobiotic in the larvae."( Thiols and polyamines in the potentiation of malathion toxicity in larval stages of the toad Bufo arenarum.
Anguiano, OL; Bergoc, RM; Cocca, C; Gauna, L; Pechen de D'Angelo, AM; Venturino, A, 2001
)
0.87
"The dermatopharmacokinetic (DPK) method of dermal tape stripping may prove to be a valuable addition to risk assessment protocols for toxic substances as it has been for the assessment of bioequivalence and bioavailability of topical dermatologic drugs."( Chemomorphic analysis of malathion in skin layers of the rat: implications for the use of dermatopharmacokinetic tape stripping in exposure assessment to pesticides.
Blancato, JN; Dary, CC; Saleh, MA, 2001
)
0.61
" Ageing may increase risk of Parkinson's disease by altering hepatic detoxification and increasing systemic bioavailability of neurotoxins."( Age-related alteration in hepatic disposition of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and pesticides.
Le Couteur, DG; McLean, AJ; Yang, MC, 2002
)
0.31
" This work aimed to evaluate the bioavailability and toxicity of MA in sediments of the IRD from the Stagnicola sp snail, taking into account the physicochemical properties of the IRD sediment."( Toxic effect and bioavailability of malathion spiked in natural sediments from the Ignacio Ramirez Dam on the snail Stagnicola sp.
Chehue, RA; Galar, MM; Gómez-Oliván, L; López López, E; Martínez-Tabche, L; Olvera, HE; Terron Sierra, O, 2002
)
0.59
" This shows that following a dermal exposure, the absorption rate governs the urinary excretion rate of malathion metabolites because the dermal absorption rate is much slower than biotransformation and renal clearance processes."( A toxicokinetic model of malathion and its metabolites as a tool to assess human exposure and risk through measurements of urinary biomarkers.
Bouchard, M; Brunet, RC; Carrier, G; Dumoulin, MJ; Gosselin, NH; Samuel, O, 2003
)
0.84
" The bioavailability of all three insecticides was significantly altered when diet concentrations in the flasks were > or = 150 mg/L."( Influences of a laboratory diet and natural seston on the bioavailability of carbaryl, chlorpyrifos, and malathion to black fly larvae (Diptera: Simuliidae) in an acute toxicity test.
Noblet, R; Overmyer, JP, 2003
)
0.53
" Furthermore, these can indicate if degradation or binding could reduce the bioavailability of chemicals, and can also set the basis for the establishment of safe concentrations."( Bioavailability and effects of malathion in artificial sediments on Simocephalus vetulus (Cladocera: Daphniidae).
Martínez-Jerónimo, F; Martínez-Tabche, L; Olvera-Hernández, E, 2004
)
0.61
"This study investigated the effect of soil organic matter content on the bioavailability of malathion to the common nightcrawler, Lumbricus terrestris."( Assessment of the effect of varying soil organic matter content on the bioavailability of malathion to the common nightcrawler, Lumbricus terrestris L.
Henson-Ramsey, H; Kennedy-Stoskopf, S; Levine, JF; Shea, D; Stoskopf, MK; Taylor, SK, 2008
)
0.79
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
"Organophosphates insecticides (OPs) are one of the major environmental pollutants and their interaction with human serum albumin (HSA) has been shown to have significant effects on their bioavailability which is related to toxicokinetics and toxicodynamics in human body."( Mechanism of interactions between organophosphorus insecticides and human serum albumin: Solid-phase microextraction, thermodynamics and computational approach.
Bojko, B; Liu, F; Pawliszyn, J; Peng, W; Wang, X; Zhao, H, 2020
)
0.56

Dosage Studied

Stumus vulgaris was not induced by 180 or 300 mg/kg prochloraz. No difference in BuChE activity following dosing with malathion was apparent in comparison with controls. Females reared from larvae dosed with deltamethrin had significantly higher titers of sex pheromone than those treated with endosulfan,malathion, or carbaryl.

ExcerptRelevanceReference
"To evaluate the efficacy and to determine the minimum effective dosage of four pediculicides against head louse infestation, as well as to select a safe, effective, practical, and cheap agent, 1,657 infested school children in 25 primary schools in Szu-Hu, Kou-Hu, and Ku-Keng Districts of Yunlin County were treated and 1,611 of them were examined."( Evaluation of efficacy of four pediculicides against head louse (Pediculus capitis) infestation.
Chow, CY; Chuang, CH; Chung, WC; Fan, PC; Hsu, HM; Kuo, CL; Lin, CY, 1992
)
0.28
" Mosquitoes treated with Scourge required more time and a higher dosage to respond in a physiological manner similar to those treated with either of the candidate adulticides."( Comparison of the synthetic pyrethroids Esbiothrin and Bioresmethrin with Scourge and Cythion against adult mosquitoes in a laboratory wind tunnel.
Boike, AH; Coughlin, JS; Floore, TG; Greer, MJ; Rathburn, CB, 1992
)
0.28
"The adulticidal effect of ULV and thermal fog malathion, Scourge and naled was tested at 2x label dosage (1."( Effects of ultra-low volume and thermal fog malathion, Scourge and naled applied against caged adult Culicoides furens and Culex quinquefasciatus in open and vegetated terrain.
Jordan, S; Linley, JR, 1992
)
0.8
" A comparison of results from dose-response curves with isoboles showed good agreement."( Evaluation of experimental combined toxicity by use of dose-frequency curves: comparison with theoretical additivity as well as independence.
Dittrich, P; Lenk, W; Pöch, G; Reiffenstein, RJ; Schuster, A, 1990
)
0.28
" Therefore, this screening method is able to detect the presence of drugs even a therapeutic-level dosages, with the exception of compounds such as haloperidol, which have extremely low therapeutic dosage levels."( [Screening of drugs and chemicals by wide-bore capillary gas chromatography. II. Detection of drugs and chemicals in the blood].
Fujiwara, Y; Fukuma, Y; Hara, K; Hieda, Y; Kageura, M; Kashimura, S; Morinaga, M; Takamoto, M, 1990
)
0.28
" In addition, our studies also showed the dose-response relationship, and that this relationship gave the same as the specific criterion."( [Studies on the safety assessment of pesticides by means of immunological criteria].
Zhou, YZ, 1989
)
0.28
" No dose-response relationships were observed for either treatment."( Cytogenetic effects of malathion insecticide on somatic and germ cells of mice.
Beçak, W; Pereira, CA; Ribeiro, LR; Salvadori, DM, 1988
)
0.59
" These studies suggest that the total penetration of malathion resulting from daily topical dosing without daily washing may be predicted from a single-dose application to the same unwashed site at an equivalent surface concentration, and also that repeated washing with soap and water may significantly decrease the barrier function of guinea-pig skin."( Percutaneous absorption of malathion in the guinea-pig: effect of repeated topical application.
Bucks, DA; Maibach, HI; Marty, JP, 1985
)
0.82
" Several techniques for applying the aerosols to an inhabited locality were investigated, and it was found that excellent control of adult mosquitos could be obtained with a dosage of 438 ml/ha."( Ultra-low-volume ground aerosols of technical malathion for the control of Aedes aegypti L.
Jatanasen, S; Mathis, HL; Mount, GA; Pant, CP, 1971
)
0.51
" Changes in the dose-response curve of adults could be approximately described by a dose-modification factor."( Selection for malathion-resistance in Drosophila melanogaster.
Morton, RA; Singh, RS, 1981
)
0.62
" Suppression occurred after a dosage which produced cholinergic effects but was absent after a lower dosage which did not produce cholinergic signs."( The effects of organophosphate-induced cholinergic stimulation on the antibody response to sheep erythrocytes in inbred mice.
Casale, GP; Cohen, SD; DiCapua, RA, 1983
)
0.27
" Starlings (Stumus vulgaris), however, appeared not to be induced by 180 or 300 mg/kg prochloraz, and no difference in BuChE activity following dosing with malathion was apparent in comparison with controls."( The study of interactive effects of pollutants: a biomarker approach.
Johnston, G, 1995
)
0.49
" Doubling the diagnostic dosage of temephos for larval Ae."( Resistance in some Caribbean populations of Aedes aegypti to several insecticides.
Rawlins, SC; Wan, JO, 1995
)
0.29
" The latter assessments were based on comparisons between laboratory-derived dose-response curves and maximum concentrations reached in standing water calculated using standard application rates."( Susceptibility of first instar Toxorhynchites splendens to malathion, naled and resmethrin.
Hallmon, CF; Hester, PG; Olson, MA; Schreiber, ET; Shaffer, KR; Tietze, NS, 1993
)
0.53
" All compounds were tested at the recommended diagnostic dosage and exposure time."( Insecticide susceptibility status of Anopheles koliensis (Diptera: Culicidae) in northeastern Irian Jaya, Indonesia.
Annis, BA; Arbani, PR; Bahang, ZH; Bangs, MJ; Hamzah, N, 1993
)
0.29
" Acetylcholinesterase activity of approximately 80% of both populations was not inhibited by a standard dosage of propoxur."( Insecticide cross-resistance spectra and underlying resistance mechanisms of Sri Lankan anopheline vectors of malaria.
Karunaratne, SH, 1999
)
0.3
" When the order of administration of pesticides and antigens was reversed, no differences in immune function between the control and dosed groups were apparent, indicating that frogs exposed to pathogens prior to pesticide exposure can still respond."( Immunosuppression in the northern leopard frog (Rana pipiens) induced by pesticide exposure.
Albert, A; Dixon, B; Drouillard, KG; Gilbertson, MK; Haffner, GD, 2003
)
0.32
" administration of the combination of malathion + superphosphate or urea on Najdi sheep were evaluated in sheep dosed as untreated controls, malathion-treated at 25 mg/kg/d, superphosphate-treated at 450 mg/kg/d, urea-treated at 450 mg/kg/d, malathion-treated at 25 mg/kg/d + superphosphate treated at 450 mg/kg/d, or malathion treated at 25 mg/kg/d + urea treated at 450 mg/kg/d."( Effects of malathion plus superphosphate or urea on Najdi sheep.
Adam, SE; Al-Qarawi, AA, 2003
)
0.98
" We tested the activities of LDH and alkaline phosphatase (ALP) in the medium in different isocarbophos dosage conditions."( [Effects of isocarbophos on the integrity of epidermic cell membrane of human skin].
Guo, M; Mao, Y; Yang, Y; Zhang, H; Zhou, M, 2001
)
0.31
" The LDH activities of the dosage groups were statistically different from those of the positive and negative groups."( [Effects of isocarbophos on the integrity of epidermic cell membrane of human skin].
Guo, M; Mao, Y; Yang, Y; Zhang, H; Zhou, M, 2001
)
0.31
" From these results, we predicted that young animals would be more sensitive to diazinon, which, in fact, was the case: When postnatal day (PND) 17 or adult rats were given a dosage of 75 mg/kg diazinon, adult brain cholinesterase (ChE) was only inhibited 38%, while the brain ChE in the PND 17 animals showed much more inhibition (75%)."( Further assessment of an in vitro screen that may help identify organophosphorus pesticides that are more acutely toxic to the young.
Moser, VC; Padilla, S; Sung, HJ, 2004
)
0.32
" However, females reared from larvae dosed with deltamethrin had significantly higher titers of sex pheromone than those treated with endosulfan, malathion, or carbaryl, or control individuals."( Sex pheromones and reproductive behavior of Spodoptera litura (Fabricius) moths reared from larvae treated with four insecticides.
Du, J; Huang, Y; Wei, H, 2004
)
0.52
"3-m sprint track interfaced with a laptop computer 24 hrs prior to dosing and again at 4, 24, 120, and 312 hrs post-dose."( Effect of acute exposure to malathion and lead on sprint performance of the western fence lizard (Sceloporus occidentalis).
Holem, RR; Hopkins, WA; Talent, LG, 2006
)
0.63
" The reproducibility of the method was assessed by three tests with alpha-cypermethrin against a reference strain, which produced dose-response lines that did not differ significantly (chi(2)=1."( Assessment of susceptibility of the poultry red mite Dermanyssus gallinae (Acari: Dermanyssidae) to some acaricides using an adapted filter paper based bioassay.
Ford, HL; Thind, BB, 2007
)
0.34
" For mixtures with malathion on algae, dose-response surfaces were made and the results tested against the model of concentration addition (CA) and independent action (IA)."( Organophosphorous insecticides as herbicide synergists on the green algae Pseudokirchneriella subcapitata and the aquatic plant Lemna minor.
Abbaspoor, M; Cedergreen, N; Munkegaard, M, 2008
)
0.67
" Preincubation with unlabelled pesticide in vitro or dosing of F344 rats with pesticide in vivo resulted in a reduction in subsequent albumin radiolabelling with (3)H-DFP, the decrease in which was used to quantify pesticide binding."( Albumin binding as a potential biomarker of exposure to moderately low levels of organophosphorus pesticides.
Carter, WG; Lister, T; Ray, DE; Tarhoni, MH, 2008
)
0.35
" Detailed pharmacologic dose-response curves of selected inhibitors were also measured in high-throughput fashion to validate the method."( Rapid and label-free screening of enzyme inhibitors using segmented flow electrospray ionization mass spectrometry.
Kennedy, RT; Li, Q; Pei, J, 2010
)
0.36
"2 mg/ml) of the gulonic acid lactone-methanol solution, and the concentrations (500 ng/ml) of organic phosphorus pesticide are same, to determine the best dosage of gulonic acid lactone."( [Research the role of gulonic acid lactone in the five kinds of organic phosphorus pesticide detection].
Du, H; Pan, X; Shao, H; Yan, H, 2010
)
0.36
"In this batch study, the adsorption of malathion by using granular activated carbon with different parameters due to the particle size, dosage of carbons, as well as the initial concentration of malathion was investigated."( Study on the removal of pesticide in agricultural run off by granular activated carbon.
Ali, N; Endut, A; Hartini, WJ; Jusoh, A, 2011
)
0.64
") was studied following oral dosing of female Holtzmann rats (240-300 g)."( Absorption and excretion of organophosphorous insecticide biomarkers of malathion in the rat: implications for overestimation bias and exposure misclassification from environmental biomonitoring.
Chen, L; Ginevan, M; Krieger, R; Pan, C; Ross, J; Vega, H; Zhao, T, 2013
)
0.62
" The activity of GST was without consistent dose-response reaction, but generally the investigated insecticides caused the increase in GST activity."( Effects of individual and binary-combined commercial insecticides endosulfan, temephos, malathion and pirimiphos-methyl on biomarker responses in earthworm Eisenia andrei.
Hackenberger, BK; Hackenberger, DK; Lončarić, Ž; Stepić, S; Velki, M, 2013
)
0.61
" During the same period, each of the three other groups received a different dosage of B (5, 10 and 20 mg/kg/d, respectively) and malathion (100 mg/kg/d) by gastric gavage."( Boron attenuates malathion-induced oxidative stress and acetylcholinesterase inhibition in rats.
Coban, FK; Demirel, HH; Hazman, O; Ince, S; Kucukkurt, I, 2015
)
0.96
" When spiders encountered pesticide dosed prey, predation was unaffected, implying that spiders are unable to detect residues on prey."( The importance of pesticide exposure duration and mode on the foraging of an agricultural pest predator.
Brown, C; Hanna, CJ, 2015
)
0.42
" This is accomplished through linking a multi-species water quality model and a statistical dose-response model."( Optimal sensor placement for detecting organophosphate intrusions into water distribution systems.
Lahav, O; Ohar, Z; Ostfeld, A, 2015
)
0.42
" Field investigation of the dissipation rate kinetics for triadimefon and malathion during storage indicated that their half-life was twice as high when 5 times the recommended dosage was used."( Behavior of field-applied triadimefon, malathion, dichlorvos, and their main metabolites during barley storage and beer processing.
Bao, Y; Chen, J; Dai, X; Fan, B; Francis, F; Gui, Y; Jian, Q; Kong, Z; Li, M, 2016
)
0.93
" This variation has been demonstrated in Culex quinquefasciatus Say (Diptera: Culicidae), but has not been quantified using dose-response curves."( Permethrin and malathion LD
Aldridge, RL; Bloomquist, JR; Gezan, SA; Kaufman, PE; Linthicum, KJ, 2017
)
0.81
" B50 cells were exposed to either the dosing vehicle (methanol) or an acute dose of either permethrin or malathion for 6 and 24 hours."( Untargeted metabolomics of neuronal cell culture: A model system for the toxicity testing of insecticide chemical exposure.
Hayton, S; Maker, GL; Mullaney, I; Trengove, RD, 2017
)
0.67
" The effect of malathion on blood glucose concentration showed a non-monotonic dose-response curve."( Effects of exposure to malathion on blood glucose concentration: a meta-analysis.
Alvarez-Fitz, P; Flores-Alfaro, E; Moreno-Godinez, ME; Parra-Rojas, I; Ramirez-Vargas, MA; Uriostegui-Acosta, M, 2018
)
1.14
" Further, when the human condition was simulated in animals, there was deprivation in body weight and glucose levels in starved litchi seed dosed rats, causing hypoglycemia."( Methylenecyclopropyl glycine, not pesticide exposure as the primary etiological factor underlying hypoglycemic encephalopathy in Muzaffarpur, India.
Asthana, S; Das, M; Dixit, S; Kumar, A; Singh, SP; Srivastava, A; Tripathi, A, 2019
)
0.51
" The contributions of the parent insecticides and their oxons to the activities of the chlorinated samples were calculated from the concentrations of the compounds in the samples and dose-response curves for chemical standards of the compounds."( Effect of chlorination on anti-acetylcholinesterase activity of organophosphorus insecticide solutions and contributions of the parent insecticides and their oxons to the activity.
Fujita, Y; Huang, Y; Matsui, Y; Matsushita, T; Omori, K; Shirasaki, N, 2020
)
0.56
" Dose-response (DR) bioassays with pyriproxyfen were performed on populations that did not achieve 98% EI in the DD assays."( Assessment of the susceptibility status of Aedes aegypti (Diptera: Culicidae) populations to pyriproxyfen and malathion in a nation-wide monitoring of insecticide resistance performed in Brazil from 2017 to 2018.
Andrighetti, MTM; Bellinato, DF; Campos, KB; Dias, LDS; Lima, JBP; Macoris, MLDG; Martins, AJ; Obara, MT; Rodovalho, CM, 2020
)
0.77
" The optimum experimental conditions, including adsorbent dosage (0."( Application of chitosan-alginate bio composite for adsorption of malathion from wastewater: Characterization and response surface methodology.
Mehrdad Sharif, AA; Sabbagh, N; Tahvildari, K, 2021
)
0.86
" We then perform dose-response bioassays using this protocol to identify larval lethal concentrations for three commonly used insecticides (malathion, spinosad and zeta-cypermethrin) in a susceptible population."( Development and validation of a larval bioassay and selection protocol for insecticide resistance in Drosophila suzukii.
Gress, BE; Zalom, FG, 2022
)
0.92
" The slopes of the dose-response curves to most of the insecticides tested for these field populations of Ae."( Insecticide Resistance in Alabama Populations of the Mosquito Aedes albopictus.
An, M; Liu, N; Stevens, KM; Wang, Y, 2022
)
0.72
" Dose-response test of transgenic Arabidopsis thaliana further demonstrated that the Pro-197-Ala substitution conferred bensulfuron-methyl resistance."( Mutation at the 197 site and P450-mediated metabolic resistance are involved in bensulfuron-methyl resistance in Sagittaria trifolia.
Cao, S; Guan, Y; Ji, M; Liu, L; Zhao, B; Zou, Y, 2023
)
0.91
" Dose-response confirmed the detected resistances in the representative populations, and suggested that the majority of observed resistance was dose-dependent."( Target and nontarget mechanisms of AHAS inhibitor cross-resistance patterns in Cyperus difformis.
Al-Khatib, K; Ceseski, AR; Godar, AS; Ohadi, S, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
diesterA diester is a compound containing two ester groups.
ethyl esterAny carboxylic ester resulting from the formal condensation of the carboxy group of a carboxylic acid with ethanol.
organic thiophosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (67)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency17.80200.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency17.80200.025120.237639.8107AID886; AID893
LuciferasePhotinus pyralis (common eastern firefly)Potency37.23800.007215.758889.3584AID1224835
interleukin 8Homo sapiens (human)Potency74.97800.047349.480674.9780AID651758
acetylcholinesteraseHomo sapiens (human)Potency55.44740.002541.796015,848.9004AID1347395; AID1347398
15-lipoxygenase, partialHomo sapiens (human)Potency19.95260.012610.691788.5700AID887
phosphopantetheinyl transferaseBacillus subtilisPotency39.81070.141337.9142100.0000AID1490
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency48.96623.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency9.68850.006038.004119,952.5996AID1159521
TDP1 proteinHomo sapiens (human)Potency2.17470.000811.382244.6684AID686978; AID686979
GLI family zinc finger 3Homo sapiens (human)Potency27.31190.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency27.85150.000221.22318,912.5098AID1259243; AID1259381; AID743036
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency5.62340.011212.4002100.0000AID1030
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency54.84420.000657.913322,387.1992AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency25.53060.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency11.52920.000417.946075.1148AID1346784; AID1346795
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency7.51750.01237.983543.2770AID1645841
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency50.41670.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency22.99640.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency46.87570.001530.607315,848.9004AID1224821; AID1224841; AID1224842; AID1224848; AID1224849; AID1259401
farnesoid X nuclear receptorHomo sapiens (human)Potency39.81070.375827.485161.6524AID588526
pregnane X nuclear receptorHomo sapiens (human)Potency12.19720.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency42.79050.000229.305416,493.5996AID743069; AID743075; AID743079
GVesicular stomatitis virusPotency1.18510.01238.964839.8107AID1645842
cytochrome P450 2D6Homo sapiens (human)Potency28.25760.00108.379861.1304AID1645840
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency33.17610.001019.414170.9645AID588536; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency29.52010.023723.228263.5986AID588543; AID743222; AID743223
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency3.16230.035520.977089.1251AID504332
aryl hydrocarbon receptorHomo sapiens (human)Potency31.78080.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency61.13060.001723.839378.1014AID743083
activating transcription factor 6Homo sapiens (human)Potency1.94940.143427.612159.8106AID1159516
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency10.682219.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency48.96620.057821.109761.2679AID1159526
Histone H2A.xCricetulus griseus (Chinese hamster)Potency31.84890.039147.5451146.8240AID1224845
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency28.18380.354828.065989.1251AID504847
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.15850.010039.53711,122.0200AID588547
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency68.58960.000323.4451159.6830AID743065
heat shock protein beta-1Homo sapiens (human)Potency31.30460.042027.378961.6448AID743210
nuclear factor NF-kappa-B p105 subunit isoform 1Homo sapiens (human)Potency31.62284.466824.832944.6684AID651749
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency44.45890.000627.21521,122.0200AID651741; AID720636; AID743202; AID743219
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency1.00000.031610.279239.8107AID884; AID885
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency39.81070.251215.843239.8107AID504327
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
Interferon betaHomo sapiens (human)Potency1.18510.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency1.18510.01238.964839.8107AID1645842
Cellular tumor antigen p53Homo sapiens (human)Potency76.95880.002319.595674.0614AID651631
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
Nuclear receptor ROR-gammaHomo sapiens (human)Potency0.05310.026622.448266.8242AID651802
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency28.18380.009610.525035.4813AID1479145
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency1.18510.01238.964839.8107AID1645842
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency1.00001.000012.224831.6228AID885
cytochrome P450 2C9, partialHomo sapiens (human)Potency1.18510.01238.964839.8107AID1645842
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency35.48130.060110.745337.9330AID492961
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (178)

Processvia Protein(s)Taxonomy
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (54)

Processvia Protein(s)Taxonomy
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (37)

Processvia Protein(s)Taxonomy
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
virion membraneSpike glycoproteinSevere acute respiratory syndrome-related coronavirus
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (63)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID625284Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625285Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625281Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1112032Insecticidal activity against Drosophila suzukii assessed as mortality at 2.2 g/ha by direct application at 22 degC measured after 24 hr2011Pest management science, Nov, Volume: 67, Issue:11
Laboratory and field comparisons of insecticides to reduce infestation of Drosophila suzukii in berry crops.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID625292Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625280Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1105543Juvenile hormone mimicking activity against adult Sitophilus oryzae (rice weevil) infested wheat kernels assessed as suppression of progeny development at 1 to 100 ppm applied through diet for 21 days measured after 9 weeks1996Archives of insect biochemistry and physiology, , Volume: 32, Issue:3-4
Projuvenoids: synthesis and biological evaluation of sulfenylated, sulfinylated, and sulfonylated carbamates.
AID1112031Insecticidal activity against Drosophila suzukii assessed as mortality at 2.3 g/ha by direct application at 22 degC measured after 24 hr2011Pest management science, Nov, Volume: 67, Issue:11
Laboratory and field comparisons of insecticides to reduce infestation of Drosophila suzukii in berry crops.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID625286Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1091133Inhibition of AChE in drug-sensitive Plutella xylostella (diamondback moth) fourth-instar larvae homogenates using acetylthiocholine iodide substrate by colorimetric method1994Metal-based drugs, , Volume: 1, Issue:1
Insecticidal Effects of Organotin(IV) Compounds on Plutella Xylostella (L.) Larvae. II. Inhibitory Potencies Against Acetylcholinesterase and Evidence for Synergism in Tests With Bacillus Thuringiensis(BER.) and Malathion.
AID1091134Insecticidal activity against drug-resistant Plutella xylostella (diamondback moth) fourth-instar larvae exposed to compound through topical application followed by transfer onto fresh Brassica leaves assessed as insect mortality measured 48 hr post compo1994Metal-based drugs, , Volume: 1, Issue:1
Insecticidal Effects of Organotin(IV) Compounds on Plutella Xylostella (L.) Larvae. II. Inhibitory Potencies Against Acetylcholinesterase and Evidence for Synergism in Tests With Bacillus Thuringiensis(BER.) and Malathion.
AID625288Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1183523Larvicidal activity against Anopheles stephensi late III or early IV instar larvae assessed as mortality after 24 hrs2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis of novel thiadiazolotriazin-4-ones and study of their mosquito-larvicidal and antibacterial properties.
AID625279Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625289Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625282Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625291Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID724228Inhibition of malathion-induced apoptosis in goat testicular germ cells assessed as cell survival at 10 uM (malathion treated control = 41 +/- 6.24%)2013European journal of medicinal chemistry, Jan, Volume: 59Inhibitors of apoptosis in testicular germ cells: synthesis and biological evaluation of some novel IBTs bearing sulfonamide moiety.
AID1091135Inhibition of AChE in drug-resistant Plutella xylostella (diamondback moth) fourth-instar larvae homogenates using acetylthiocholine iodide substrate by colorimetric method1994Metal-based drugs, , Volume: 1, Issue:1
Insecticidal Effects of Organotin(IV) Compounds on Plutella Xylostella (L.) Larvae. II. Inhibitory Potencies Against Acetylcholinesterase and Evidence for Synergism in Tests With Bacillus Thuringiensis(BER.) and Malathion.
AID625283Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625290Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1081382Insecticidal activity against adult Tribolium castaneum (red flour beetle) in compound pre-treated green gram grains assessed as mortality at 20 mg/kg after 48 hr by feeding based residue method2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis of nalidixic acid based hydrazones as novel pesticides.
AID1081381Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as mortality at 0.1% at 27 +/-1 degC after 24 hr by contact based film residue method2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis of nalidixic acid based hydrazones as novel pesticides.
AID1081380Insecticidal activity against adult Callosobruchus maculatus assessed as mortality at 0.1% at 27 +/-1 degC after 24 hr by contact based film residue method2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis of nalidixic acid based hydrazones as novel pesticides.
AID625287Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (2,302)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990772 (33.54)18.7374
1990's330 (14.34)18.2507
2000's407 (17.68)29.6817
2010's551 (23.94)24.3611
2020's242 (10.51)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.06 (24.57)
Research Supply Index7.83 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index159.43 (26.88)
Search Engine Supply Index3.90 (0.95)

This Compound (48.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials36 (1.45%)5.53%
Reviews71 (2.86%)6.00%
Case Studies92 (3.70%)4.05%
Observational2 (0.08%)0.25%
Other2,285 (91.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (8)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized, Single-Dose, Parallel Group, Comparative Pharmacokinetic (PK) Study to Evaluate Malathion Gel 0.5% Versus Ovide (Malathion) Lotion 0.5% in Patients With Pediculosis Capitis [NCT00927407]Phase 124 participants (Actual)Interventional2009-07-31Completed
A Randomised, Double-Blind, Multicentre Study to Compare the Efficacy and Tolerability of Oral Ivermectin to Malathion 0.5% Lotion in the Treatment of Head Lice Infestation [NCT00819520]Phase 3812 participants (Actual)Interventional2004-02-29Completed
A Multi-Center Phase III Study to Evaluate Ovide Lotion 0.5% Formulation, for the Control of Head Lice in Pediatric Subjects and Adult Subjects With Pediculosis Capitis [NCT00927472]Phase 3254 participants (Actual)Interventional2009-08-31Completed
A Multi-Center Phase III Study to Evaluate MALG, a Novel Malathion 0.05%Formulation, for the Control of Head Lice in Pediatric and Adult Subjects With Pediculosis Capitis [NCT00244439]Phase 3360 participants (Actual)Interventional2005-12-31Completed
Phase II, Multi-Center, Open-Label, Safety and Tolerance Study of a Novel Malathion Formulation in Infants and Toddlers With Pediculosis Capitis [NCT00752973]Phase 2/Phase 312 participants (Actual)Interventional2008-09-30Completed
Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands [NCT03236168]Phase 3118 participants (Actual)Interventional2017-08-01Completed
A Multi-Center Phase III Study to Evaluate Malathion Gel 0.5% Formulation, for the Control of Head Lice in Pediatric Subjects and Adult Subjects With Pediculosis Capitis [NCT00963508]Phase 3403 participants (Actual)Interventional2009-08-31Completed
Safety and Efficacy of a 100% Dimethicone Pediculocide in School-Age Children [NCT02213055]Phase 297 participants (Actual)Interventional2009-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT00752973 (7) [back to overview]Participants Clinically Cured of Head Lice 14 Days After Last Treatment
NCT00752973 (7) [back to overview]Participants With the Clinical Evidence of Cholinesterase Inhibition
NCT00752973 (7) [back to overview]Participants With the Clinical Evidence of Cholinesterase Inhibition
NCT00752973 (7) [back to overview]Participants With the Clinical Evidence of Cholinesterase Inhibition
NCT00752973 (7) [back to overview]Evaluation of the Local Safety of Malathion Gel, 0.5% Based Upon Reported Adverse Events and Observed Scalp Reactions.
NCT00752973 (7) [back to overview]Participants With a Change in Cholinesterase Level at 1 Hour (Day 0).
NCT00752973 (7) [back to overview]Participants With a Change in Cholinesterase Level at 24 Hrs (1 Day).
NCT00927472 (10) [back to overview]Proportion of All Randomized Subjects Who Were Treated and Returned for at Least One Post-treatment Visit (Non-LOCF).
NCT00927472 (10) [back to overview]Proportion of All Randomized Subjects Who Were Treated and Returned for at Least One Post-treatment Visit.(LOCF)
NCT00927472 (10) [back to overview]Proportion of Index Subjects Free of Any of Lice 14 Days After Their Last Treatment.
NCT00927472 (10) [back to overview]Proportion of Index Subjects Lice-free 14 Days After Their Last Treatment
NCT00927472 (10) [back to overview]Proportion of Index Subjects Lice-free 2 Weeks After Their Last Treatment
NCT00927472 (10) [back to overview]Proportion of Subjects Who Were Considered Treatment Success 14 Days After Their First Treatment in the Efficacy ITT (LOCF))
NCT00927472 (10) [back to overview]Proportion of Subjects Who Were Considered Treatment Success 14 Days After Their First Treatment in the Efficacy ITT (Non LOCF))
NCT00927472 (10) [back to overview]Proportion of Subjects Who Were Considered Treatment Success 14 Days After Their First Treatment in the Modified ITT (LOCF)
NCT00927472 (10) [back to overview]Proportion of Subjects Who Were Considered Treatment Success 14 Days After Their First Treatment in the Modified ITT (Non LOCF)
NCT00927472 (10) [back to overview]Proportion of Subjects Who Were Considered Treatment Success 14 Days After Their First Treatment in the PPP
NCT00963508 (2) [back to overview]Proportion of Index Subjects Free of Any Lice 14 Days After Their Last Treatment in the Modified ITT (LOCF)
NCT00963508 (2) [back to overview]Proportion of Subjects Who Were Considered a Treatment Success 14 Days After Their First Treatment in the Modified ITT (LOCF).
NCT02213055 (1) [back to overview]Number of Participants Free of Live Head Lice and Free of Viable Eggs
NCT03236168 (1) [back to overview]Number of Participants With Headlice

Participants Clinically Cured of Head Lice 14 Days After Last Treatment

No live lice (including adults and nymphs) and nits at Day 7±1 and final lice assessment on either Day 14 (subjects not requiring retreatment) or Day 21 (for retreated subjects). (NCT00752973)
Timeframe: Day 7±1 and Day 14 or Day 21

Interventionparticipants cured of lice (Number)
MALG (Malathion Gel, 0.5% )Treatment Arm12

[back to top]

Participants With the Clinical Evidence of Cholinesterase Inhibition

"Participants with any of the following symptoms of cholinesterase inhibition as numbered below were considered to have Clinical evidence cholinesterase inhibition :~Abnormal heart rate.~Diarrhea or abdominal cramps.~Inappropriate sweating.~Pupillary miosis (constriction).~Respiratory difficulty such as chest tightness or wheezing.~One participants had wheezing as medical history which continued without increase in severity throughout the treatment." (NCT00752973)
Timeframe: at 1 hr (Day 0)

Interventionpercentage of participants (Number)
MALG (Malathion Gel, 0.5% )Treatment Arm8.3

[back to top]

Participants With the Clinical Evidence of Cholinesterase Inhibition

"Participants with any of the following symptoms of cholinesterase inhibition as numbered below were considered to have Clinical evidence of cholinesterase inhibition :~Abnormal heart rate.~Diarrhea or abdominal cramps.~Inappropriate sweating.~Pupillary miosis (constriction).~Respiratory difficulty such as chest tightness or wheezing.~One participants had wheezing as medical history which continued without increase in severity throughout the treatment." (NCT00752973)
Timeframe: at 24 hrs (Day 1)

Interventionpercentage of participants (Number)
MALG (Malathion Gel, 0.5% )Treatment Arm0

[back to top]

Participants With the Clinical Evidence of Cholinesterase Inhibition

"Participants with any of the following symptoms of cholinesterase inhibition as numbered below were considered to have Clinical evidence of cholinesterase inhibition.~Abnormal heart rate.~Diarrhea or abdominal cramps.~Inappropriate sweating.~Pupillary miosis (constriction).~Respiratory difficulty such as chest tightness or wheezing.~One participant had wheezing as medical history which continued without increase in severity throughout the treatment." (NCT00752973)
Timeframe: at Baseline

Interventionpercentage of participants (Number)
MALG (Malathion Gel, 0.5% )Treatment Arm8.3

[back to top]

Evaluation of the Local Safety of Malathion Gel, 0.5% Based Upon Reported Adverse Events and Observed Scalp Reactions.

To evaluate the safety of Malathion Gel, 0.5% based upon reported adverse events and observed scalp reactions. Additional safety assessments included eye Irritation. (NCT00752973)
Timeframe: Participants were followed for a minimum of 14 days (1 treatment) and a maximum of 21 days (2 treatments)

Interventionparticipants (Number)
No sign of irritationSlight noticeable erythema + slight infiltrationNo conjunctival irritation
MALG (Malathion Gel, 0.5% )Treatment Arm11112

[back to top]

Participants With a Change in Cholinesterase Level at 1 Hour (Day 0).

"Each patient (aged 6 - 24 months) was assessed at 1 hour (Day 0). The mean percent change (reduction) in plasma and RBC cholinesterase activity from baseline to 1 hr after application was calculated and accompanied by 95% confidence intervals.~If the half-widths of the derived confidence intervals are sufficiently narrow, it will demonstrate that any observed reductions in plasma and RBC cholinesterase activity fall within established safety guidelines.~Concentration of RBC-cholinesterase (RBC-ChE) and plasma cholinesterase were obtained at baseline, at 1 hr (Day 0) and at 24 hrs (Day 1) after the application of the treatment.~Mean percent change (reduction) = (Post treatment value - Baseline)/ Baseline x100." (NCT00752973)
Timeframe: Change from Baseline to 1 hour

Interventionpercentage change in cholinesterase (Mean)
PlasmaRBC cholinesterase
MALG (Malathion Gel, 0.5% )Treatment Arm-1.8-0.5

[back to top]

Participants With a Change in Cholinesterase Level at 24 Hrs (1 Day).

"Each patient was assessed at Day 1 and the mean percent reduction in plasma and RBC cholinesterase activity from baseline to 24 hr after application was calculated and accompanied by 95% confidence intervals.~Concentration of RBC-cholinesterase (RBC-ChE) and plasma cholinesterase were obtained at baseline, at 1 hr (Day 0) and at 24 hrs (Day 1) after the application of the treatment.~Mean percent reduction = (Post treatment value - Baseline)/ Baseline x100." (NCT00752973)
Timeframe: Change from baseline to 24 hrs (1 day)

Interventionpercentage change in cholinesterase (Mean)
Plasma CholinesteraseRBC Cholinesterase
MALG (Malathion Gel, 0.5% )Treatment Arm-1.71.4

[back to top]

Proportion of All Randomized Subjects Who Were Treated and Returned for at Least One Post-treatment Visit (Non-LOCF).

"Treatment Success in the Modified ITT (non-LOCF)~The Modified ITT included all randomized subjects who were treated and returned for at least one post-treatment visit.~Subjects with missing efficacy data were included first with LOCF and then with non-LOCF" (NCT00927472)
Timeframe: 3 weeks

Interventionpercentage of subjects (Number)
Malathion Gel86.78
Nix Creme Rinse68.47

[back to top]

Proportion of All Randomized Subjects Who Were Treated and Returned for at Least One Post-treatment Visit.(LOCF)

"Treatment Success in the Modified Intention to Treat (Modified ITT) (LOCF)~The Modified ITT included all randomized subjects who were treated and returned for at least one post-treatment visit. Subjects with missing efficacy data were included first with LOCF and then with non-LOCF" (NCT00927472)
Timeframe: 3 weeks

Interventionpercentage of subjects (Number)
Malathion Gel91.74
Nix Creme Rinse72.97

[back to top]

Proportion of Index Subjects Free of Any of Lice 14 Days After Their Last Treatment.

"Treatment Success was evaluated using the Efficacy Intention to Treat (eITT) (LOCF) Efficacy ITT (eITT) was considered definitive.~The primary efficacy variable was the proportion of index subjects who were considered a Treatment Success 14 days after their last treatment (Day 14 visit if only treated on Day 1, Day 21 visit if treated on Day 1 and Day 7).~Index subject: 95 from 254 randomized (the youngest subject in the household who met index case criteria( having nits and at least 3 live lice))" (NCT00927472)
Timeframe: 3 weeks

Interventionpercentage of subjects (Number)
Malathion Gel82.98
Nix Creme Rinse62.50

[back to top]

Proportion of Index Subjects Lice-free 14 Days After Their Last Treatment

"Treatment Success in the Per Protocol Population (PPP)~The PPP included all subjects who complied strictly with the protocol and had outcome data for all required visits. Superiority analysis in the PPP was considered to be supportive." (NCT00927472)
Timeframe: 3 weeks

Interventionpercentage of subjects (Number)
Malathion Gel91.30
Nix Creme Rinse71.70

[back to top]

Proportion of Index Subjects Lice-free 2 Weeks After Their Last Treatment

"Treatment Success in the Efficacy Intention to Treat (eITT) (No LOCF)~The primary efficacy variable was the proportion of index subjects who were considered a Treatment Success 14 days after their last treatment (Day 14 visit if only treated on Day 1, Day 21 visit if treated on Day 1 and Day 7)." (NCT00927472)
Timeframe: 3 weeks

Interventionpercentage of subjects (Number)
Malathion Gel78.72
Nix Creme Rinse58.33

[back to top]

Proportion of Subjects Who Were Considered Treatment Success 14 Days After Their First Treatment in the Efficacy ITT (LOCF))

"Treatment Success in the Efficacy ITT (LOCF)~The secondary efficacy variable was the proportion of index subjects who were lice-free 14 days after their first treatment." (NCT00927472)
Timeframe: 3 weeks

Interventionpercentage of subjects (Number)
Malathion Gel80.95
Nix Creme Rinse70.00

[back to top]

Proportion of Subjects Who Were Considered Treatment Success 14 Days After Their First Treatment in the Efficacy ITT (Non LOCF))

"Treatment Success in the Efficacy ITT (non LOCF)~The secondary efficacy variable was the proportion of index subjects who were lice-free 14 days after their first treatment." (NCT00927472)
Timeframe: 3 weeks

Interventionpercentage of subjects (Number)
Malathion Gel76.19
Nix Creme Rinse65.00

[back to top]

Proportion of Subjects Who Were Considered Treatment Success 14 Days After Their First Treatment in the Modified ITT (LOCF)

"Treatment Success in the Modified ITT (LOCF)~The secondary efficacy variable was the proportion of index subjects who were lice-free 14 days after their first treatment.~The evaluations in the Modified ITT was considered supportive." (NCT00927472)
Timeframe: 3 weeks

Interventionpercentage of subjects (Number)
Malathion Gel90.91
Nix Creme Rinse82.02

[back to top]

Proportion of Subjects Who Were Considered Treatment Success 14 Days After Their First Treatment in the Modified ITT (Non LOCF)

"Treatment Success in the Modified ITT (non LOCF)~The secondary efficacy variable was the proportion of index subjects who were lice-free 14 days after their first treatment.~The evaluations in the Modified ITT was considered supportive." (NCT00927472)
Timeframe: 3 weeks

Interventionpercentage of subjects (Number)
Malathion Gel85.45
Nix Creme Rinse76.40

[back to top]

Proportion of Subjects Who Were Considered Treatment Success 14 Days After Their First Treatment in the PPP

"Treatment Success in the PPP~The secondary efficacy variable was the proportion of index subjects who were lice-free 14 days after their first treatment.~The evaluations in the PPP was considered supportive." (NCT00927472)
Timeframe: 3 weeks

Interventionpercentage of subjects (Number)
Malathion Gel90.38
Nix Creme Rinse80.95

[back to top]

Proportion of Index Subjects Free of Any Lice 14 Days After Their Last Treatment in the Modified ITT (LOCF)

"The primary efficacy variable was the proportion of index subjects who were considered a Treatment Success 14 days after their last treatment (Day 14 visit if only treated on Day 1, Day 21 visit if treated on Day 1 and Day 7)~Treatment Success in the Efficacy ITT (LOCF)~index subjects: 150 from 403 randomized (the youngest subject in the household that met the index case criteria (having nits and at least 3 live lice))" (NCT00963508)
Timeframe: 3 weeks

Interventionpercentage of subjects (Number)
Malathion Gel86.67
Nix Crème Rinse45.33

[back to top]

Proportion of Subjects Who Were Considered a Treatment Success 14 Days After Their First Treatment in the Modified ITT (LOCF).

"The secondary efficacy variable was the proportion of subjects who were considered a Treatment Success 14 days after their first treatment.~Treatment Success in the Efficacy ITT (LOCF)" (NCT00963508)
Timeframe: 3 weeks

Interventionpercentage of subjects (Number)
Malathion Gel89.90
Nix Crème Rinse55.43

[back to top]

Number of Participants Free of Live Head Lice and Free of Viable Eggs

"A determination of head lice effectiveness, measured by number of subjects free of live lice and by number of subjects free of viable eggs, was calculated using two week post-treatment data as the primary study outcome. Measurements were calculated at Day 1 (day after first treatment) and Day 14.~At diagnosis, 55 subjects had viable eggs with three subjects meeting enrollment criteria for three or more live lice." (NCT02213055)
Timeframe: Day after first treatment and Day 14 of study

InterventionParticipants (Number)
Day 1 Free of live liceDay 14 Free of live liceDay 1 Free of viable eggsDay 14 Free of viable eggs
LiceMD57553246

[back to top]

Number of Participants With Headlice

Assessed in the study population by physical examination of hair (NCT03236168)
Timeframe: 2 Weeks after treatment

InterventionParticipants (Count of Participants)
Intervention Arm3

[back to top]